KR101571591B1 - Organic compounds and organic electro luminescence device comprising the same - Google Patents

Organic compounds and organic electro luminescence device comprising the same Download PDF

Info

Publication number
KR101571591B1
KR101571591B1 KR1020120143013A KR20120143013A KR101571591B1 KR 101571591 B1 KR101571591 B1 KR 101571591B1 KR 1020120143013 A KR1020120143013 A KR 1020120143013A KR 20120143013 A KR20120143013 A KR 20120143013A KR 101571591 B1 KR101571591 B1 KR 101571591B1
Authority
KR
South Korea
Prior art keywords
group
mmol
substituted
unsubstituted
synthesis
Prior art date
Application number
KR1020120143013A
Other languages
Korean (ko)
Other versions
KR20140074729A (en
Inventor
김회문
백영미
박호철
이창준
김태형
엄민식
신진용
Original Assignee
주식회사 두산
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 두산 filed Critical 주식회사 두산
Priority to KR1020120143013A priority Critical patent/KR101571591B1/en
Priority to PCT/KR2013/010557 priority patent/WO2014092354A1/en
Publication of KR20140074729A publication Critical patent/KR20140074729A/en
Application granted granted Critical
Publication of KR101571591B1 publication Critical patent/KR101571591B1/en

Links

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/342Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1096Heterocyclic compounds characterised by ligands containing other heteroatoms

Abstract

본 발명은 카바졸 모이어티(carbazole moiety)의 말단에 인돌(indole) 모이어티가 융합되어 기본 골격을 이루며, 이러한 기본 골격에 다양한 치환체가 결합된 신규 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것으로서, 상기 화합물을 하나 이상의 유기층, 바람직하게는 발광층에 포함함으로써, 소자의 발광효율, 구동 전압, 수명 등이 향상될 수 있다.The present invention relates to a novel compound in which an indole moiety is fused at the terminal of a carbazole moiety to form a basic skeleton and various substituents are bonded to the basic skeleton, and an organic electroluminescent device including the novel compound , The luminous efficiency, driving voltage, lifetime, etc. of the device can be improved by including the compound in at least one organic layer, preferably a light emitting layer.

Description

유기 화합물 및 이를 포함하는 유기 전계 발광 소자{ORGANIC COMPOUNDS AND ORGANIC ELECTRO LUMINESCENCE DEVICE COMPRISING THE SAME}TECHNICAL FIELD [0001] The present invention relates to an organic compound and an organic electroluminescent device including the organic compound.

본 발명은 유기 전계 발광 소자용 재료로서 사용될 수 있는 신규 유기 화합물 및 이를 포함하여 소자의 발광효율, 구동전압, 수명 등이 향상되는 유기 전계 발광 소자에 관한 것이다.
The present invention relates to a novel organic compound which can be used as a material for an organic electroluminescent device, and an organic electroluminescent device including the same, which improves the luminous efficiency, driving voltage and lifetime of the device.

1950년대 Bernanose의 유기 박막 발광 관측을 시점으로 하여, 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광(electroluminescent, EL) 소자(이하, 간단히 '유기 EL 소자'로 칭함)에 대한 연구가 이어져 오다가, 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층구조의 유기 EL 소자가 제시되었다. 이후, 고효율, 고수명의 유기 EL 소자를 만들기 위하여, 소자 내 각각의 특징적인 유기물 층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다. A study on organic electroluminescent (EL) devices (hereinafter simply referred to as 'organic EL devices') led to blue electroluminescence using anthracene single crystals in 1965, starting from the observation of organic thin film emission of Bernanose in the 1950s In 1987, a layered organic EL device was proposed by Tang divided into a hole layer and a functional layer of a light emitting layer. Thereafter, in order to make a high efficiency and high number of organic EL devices, each organic EL device has been developed in a manner of introducing each characteristic organic material layer in the device, leading to the development of specialized materials used therefor.

유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 유기물층으로 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 이때, 유기물층으로 사용되는 물질은 그 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다.In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected into the organic layer in the anode, and electrons are injected into the organic layer in the cathode. When the injected holes and electrons meet, an exciton is formed. When the exciton falls to the ground state, light is emitted. At this time, the material used as the organic material layer can be classified into a light emitting material, a hole injecting material, a hole transporting material, an electron transporting material, an electron injecting material and the like depending on its function.

발광 물질은 발광색에 따라 청색, 녹색, 적색 발광 물질과, 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 물질로 구분될 수 있다. 또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 물질로서 호스트/도판트 계를 사용할 수 있다. The luminescent material can be classified into blue, green and red luminescent materials according to luminescent colors and yellow and orange luminescent materials necessary for realizing better natural colors. Further, in order to increase the color purity and to increase the luminous efficiency through energy transfer, a host / dopant system can be used as a luminescent material.

도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 이때, 인광 재료의 개발은 이론적으로 형광에 비해 4배까지의 발광 효율을 향상시킬 수 있기 때문에, 인광 도판트 뿐만 아니라 인광 호스트 재료들에 대한 연구가 많이 진행되고 있다. The dopant material can be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. At this time, since the phosphorescent material can theoretically improve the luminous efficiency up to 4 times as compared with the fluorescent material, researches on phosphorescent host materials as well as phosphorescent dopants have been conducted.

현재까지 정공 주입층, 정공 수송층. 정공 차단층, 전자 수송층으로는 NPB, BCP, Alq3 등이 널리 알려져 있으며, 발광 재료로는 안트라센 유도체들이 형광 도판트/호스트 재료로서 보고되고 있다. 특히, 발광 재료 중 효율 향상 측면에서 큰 장점을 가지고 있는 인광 재료들은 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물이 청색(blue), 녹색(green), 적색(red) 도판트 재료로 사용되고 있으며, 현재까지는 CBP가 인광 호스트 재료로 높은 특성을 나타내고 있다.Up to now, hole injecting layer, hole transporting layer. NPB, BCP, and Alq 3 are widely known as the hole blocking layer and the electron transporting layer, and anthracene derivatives as a luminescent material have been reported as fluorescent dopant / host material. In particular, the phosphor has a great advantage in improving the efficiency aspects of the light-emitting material materials Firpic, Ir (ppy) 3, (acac) Ir (btp) 2 Ir metal complex compound is blue (blue), which includes the same as the green ( green and red dopant materials, and CBP is a phosphorescent host material.

그러나, 기존의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮아 열적 안정성이 매우 좋지 않기 때문에, OLED 소자에서의 수명 측면에서 만족할 만한 수준이 되지 못하는 실정이다. 따라서, 더욱 성능이 뛰어난 재료의 개발이 요구되고 있다.
However, existing materials have an advantage in terms of luminescence properties, but their thermal stability is not very good due to their low glass transition temperature, so that they are not satisfactory in terms of lifetime in OLED devices. Therefore, development of materials with higher performance is required.

본 발명은 높은 유리 전이온도로 인해 열적 안정성이 우수하면서, 정공과 전자의 결합력을 향상시킬 수 있는 신규 유기 화합물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a novel organic compound capable of improving the bonding force between holes and electrons while having excellent thermal stability due to a high glass transition temperature.

또, 본 발명은 상기 신규 유기 화합물을 포함하여 구동전압, 발광효율 등이 향상된 유기 전계 발광 소자를 제공하는 것을 목적으로 한다.
It is another object of the present invention to provide an organic electroluminescent device including the novel organic compound and having improved driving voltage, luminous efficiency, and the like.

본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:The present invention provides a compound represented by the following formula (1): < EMI ID =

Figure 112012102547714-pat00001
Figure 112012102547714-pat00001

상기 화학식 1에서,In Formula 1,

R5와 R6, R6와 R7, 및 R7과 R8 중 적어도 하나는 하기 화학식 2와 결합하여 축합 고리를 형성하고;At least one of R 5 and R 6 , R 6 and R 7 , and R 7 and R 8 is bonded to the following formula 2 to form a condensed ring;

Figure 112012102547714-pat00002
Figure 112012102547714-pat00002

상기 화학식 2에서,In Formula 2,

R9와 R10, R10과 R11, 및 R11과 R12 중 적어도 하나는 상기 화학식 1과 결합하여 축합 고리를 형성하고;At least one of R 9 and R 10, R 10 and R 11 , and at least one of R 11 and R 12 is bonded to Formula 1 to form a condensed ring;

축합고리를 비(非)형성하는 R1 내지 R12 는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, C6~C40의 아릴알킬기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 및 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 이들은 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며,R 1 to R 12 which form a condensed ring are the same or different and are each independently selected from the group consisting of hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C 1 to C 40 alkyl group, of a C 2 ~ C 40 alkenyl group, a substituted or unsubstituted C 2 ~ C 40 alkynyl group, a substituted or unsubstituted C 6 ~ C 40 aryl group, a substituted or unsubstituted nuclear atoms of 5 to 40 of the A substituted or unsubstituted C 6 to C 40 arylamine group, a substituted or unsubstituted C 1 to C 40 alkylamine group, a substituted or unsubstituted C 6 to C 40 arylamine group, a substituted or unsubstituted C 6 to C 40 arylamine group, of 6 ~ C 40 aryl group, a substituted or unsubstituted C 3 ~ C 40 cycloalkyl group, a substituted or unsubstituted nuclear atoms to C40 heterocycloalkyl group, substituted or non-substituted of unsubstituted C 1 ~ C 40 alkyl a silyl group, a substituted or unsubstituted C 1 ~ C 40 alkyl group of boron, and a substituted or unsubstituted C 6 ~ C 40 aryl boron group, a substituted or unsubstituted of Is selected from the group C 6 ~ C 40 aryl phosphine group, a substituted or unsubstituted C 6 ~ C 40 aryl phosphine oxide group, and a substituted or unsubstituted aryl silyl group of the C 6 ~ C 40 ring consisting of, all of which are adjoining To form a condensed ring,

X1 및 X2는 각각 독립적으로 O, S, Se, N(Ar1) 및 C(Ar2)(Ar3)로부터 선택되고, X1 및 X2 중에서 적어도 하나는 N(Ar1)이며, X 1 and X 2 are each independently selected from O, S, Se, N (Ar 1 ) and C (Ar 2 ) (Ar 3 ), at least one of X 1 and X 2 is N (Ar 1 )

Y1 및 Y2는 각각 독립적으로 N 및 C(R13)로부터 선택되고,Y 1 and Y 2 are each independently selected from N and C (R 13 )

R13은 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, C6~C40의 아릴알킬기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 및 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 이들은 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며,R 13 is selected from the group consisting of hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C 1 to C 40 alkyl, substituted or unsubstituted C 2 to C 40 alkenyl, substituted or unsubstituted C 2 to C 40 A substituted or unsubstituted C 6 to C 40 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 40 nucleus atoms, a substituted or unsubstituted C 6 to C 40 aryloxy group, a substituted or unsubstituted C 6 to C 40 aryl group, An unsubstituted C 1 to C 40 alkyloxy group, a substituted or unsubstituted C 6 to C 40 arylamine group, a C 6 to C 40 arylalkyl group, a substituted or unsubstituted C 3 to C 40 cycloalkyl group , A substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, a substituted or unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstituted C 1 to C 40 alkylboron group, unsubstituted C 6 ~ C 40 aryl boron group, a substituted or unsubstituted C 6 ~ C 40 aryl phosphine group, a substituted or unsubstituted C 6 ~ C 40 aryl phosphine oxide of the group And a substituted or unsubstituted C 6 to C 40 arylsilyl group, which may be bonded to adjacent groups to form a condensed ring,

Ar1 내지 Ar3는 서로 동일하거나 또는 상이하며, 각각 독립적으로 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, C6~C40의 아릴알킬기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 및 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고,Ar 1 to Ar 3 are the same or different, each independently represent a substituted or unsubstituted C 1 ~ C 40 alkyl group, a substituted or unsubstituted C 2 ~ C 40 alkenyl group, a substituted or unsubstituted C 2 ~ C 40 of the alkynyl group, a substituted or unsubstituted C 6 ~ C 40 aryl group, a substituted or unsubstituted nuclear atoms of 5 to 40 heteroaryl group, a substituted or unsubstituted C 6 ~ aryloxy of C 40 A substituted or unsubstituted C 1 to C 40 alkyloxy group, a substituted or unsubstituted C 6 to C 40 arylamine group, a C 6 to C 40 arylalkyl group, a substituted or unsubstituted C 3 to C A substituted or unsubstituted C 1 to C 40 alkylsilyl group, a substituted or unsubstituted C 1 to C 40 alkylboron group, a substituted or unsubstituted C 1 to C 40 alkyl group, , And a substituted or unsubstituted C 6 to C 40 arylboron group, a substituted or unsubstituted C 6 to C 40 arylphosphine group, a substituted or unsubstituted C 6 to C 40 aryl phosphine oxide is selected from the pin group and a substituted or unsubstituted C 6 ~ arylsilyl group consisting of C 40 ring,

상기 R1 내지 R13, Ar1 내지 Ar3 에서, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C6~C40의 아릴알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C6~C40의 아릴알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택되는 하나 이상의 치환기로 치환될 수 있다. 이때 복수개의 치환기가 도입되는 경우, 이들 치환기는 서로 동일하거나 또는 상이할 수 있다.In the above R 1 to R 13 and Ar 1 to Ar 3 , a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkynyl group, a C 6 to C 40 aryl group, a nucleus atoms of 5 to 40 heteroaryl group, an aryloxy group of a C 6 ~ C 40, C 1 ~ C 40 alkyloxy group, the C 6 ~ C 40 aryl amine group, C 6 ~ C 40 aryl group, C of A C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 arylboron group, a C 6 to an alkyl group of C 40 aryl phosphine group, C 6 to C 40 aryl phosphine oxide group, and a C 6 to C 40 aryl silyl groups are each independently selected from deuterium, halogen, cyano group, C 1 ~ C 40 of, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 of the alkynyl group, C 6 ~ C 40 aryl group, nuclear atoms heteroaryl of 5 to 40 group, C 6 ~ aryloxy C 40, C 1 ~ C 40 alkyloxy, C 6 ~ C 40 aryl amine group, C 6 ~ C 40 aryl group, a cycloalkyl group of C 3 ~ C 40 of, An aryl phosphine group of atoms, 3 to 40 heterocycloalkyl group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C 40 group of the arylboronic, C 6 ~ C 40 of, A C 6 to C 40 arylphosphine oxide group, and a C 6 to C 40 arylsilyl group. When a plurality of substituents are introduced at this time, these substituents may be the same as or different from each other.

또한, 본 발명은 양극, 음극, 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중에서 적어도 하나는 상기 화학식 1의 화합물을 포함하는 것이 특징인 유기 전계 발광 소자를 제공한다.Also, the present invention is an organic electroluminescent device comprising a cathode, a cathode, and at least one organic layer sandwiched between the anode and the cathode, wherein at least one of the one or more organic layers includes a compound of the above formula The organic electroluminescent device comprising:

여기서, 상기 1층 이상의 유기물층 중 적어도 하나는 정공 주입층, 정공 수송층, 전자수송층, 전자주입층 및 발광층으로 구성된 군으로부터 선택될 수 있으며, 발광층인 것이 바람직하다. 이때, 상기 화학식 1로 표시되는 화합물은 청색, 녹색 또는 적색의 인광 호스트 재료이다.
At least one of the one or more organic layers may be selected from the group consisting of a hole injection layer, a hole transport layer, an electron transport layer, an electron injection layer, and a light emitting layer, and is preferably a light emitting layer. At this time, the compound represented by Formula 1 is a blue, green or red phosphorescent host material.

본 발명의 화학식 1 로 표시되는 화합물은 열적 안정성 및 인광 특성이 우수하기 때문에, 유기 전계 발광 소자의 발광층에 적용될 수 있다.The compound represented by the general formula (1) of the present invention is excellent in thermal stability and phosphorescence properties and can be applied to a light emitting layer of an organic electroluminescent device.

따라서, 본 발명의 화학식 1로 표시되는 화합물을 인광 호스트 물질로 사용할 경우, 종래 호스트 물질에 비해 우수한 발광 성능, 낮은 구동전압, 높은 효율 및 장수명을 갖는 유기 전계 발광 소자를 제조할 수 있고, 나아가 성능, 수명이 크게 향상된 풀 칼라 디스플레이 패널도 제조할 수 있다.
Accordingly, when the compound represented by Formula 1 of the present invention is used as a phosphorescent host material, it is possible to manufacture an organic electroluminescent device having excellent light emitting performance, low driving voltage, high efficiency and long life time as compared with the conventional host material, , And a full color display panel having a greatly improved lifetime can be manufactured.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

<신규 화합물><Novel compound>

본 발명에 따른 신규 화합물은 카바졸 모이어티(carbazole moiety)의 말단에 인돌(indole) 모이어티가 융합되어 기본 골격을 이루며, 이러한 기본 골격에 다양한 치환체가 결합된 구조로서, 상기 화학식 1로 표시되는 것을 특징으로 한다. The novel compound according to the present invention has a structure in which an indole moiety is fused at the terminal of a carbazole moiety to form a basic skeleton and various substituents are bonded to the basic skeleton. .

이러한 화학식 1로 표시되는 화합물은 종래 유기 EL 소자용 재료 [예: 4,4-dicarbazolybiphenyl (이하, 'CBP'로 표시함)] 보다 분자량이 클 뿐만 아니라 넓은 에너지 밴드갭을 가지면서, 정공과 전자의 결합력을 높일 수 있다. 따라서, 상기 화학식 1의 화합물을 유기 EL 소자에 이용할 경우, 소자의 구동 전압, 효율(발광효율, 전력효율), 수명 및 휘도 측면이 향상될 수 있다.The compound represented by Formula 1 has a larger molecular weight than a conventional organic EL device material (e.g., 4,4-dicarbazolybiphenyl (hereinafter referred to as 'CBP')), and has a wide energy band gap, Can be increased. Accordingly, when the compound of Formula 1 is used in an organic EL device, the driving voltage, efficiency (luminous efficiency, power efficiency), lifetime and brightness of the device can be improved.

특히, 상기 화합물은 카바졸 모이어티(carbazole moiety)의 말단에 결합된 인돌(indole) 모이어티로 인해 넓은 밴드갭을 가질 뿐만 아니라, 다양한 방향족 환 치환체로 인해 분자 전체가 바이폴라(bipolar) 특성을 가지면서, 정공과 전자의 결합력을 높일 수 있기 때문에, 종래 CBP에 비해 발광층의 호스트 재료로서의 우수한 특성을 나타낼 수 있다. 이로 인해, 소자의 인광특성을 개선함과 동시에 정공 주입 능력 및/또는 수송 능력, 발광효율, 구동전압, 수명 특성 등이 개선될 수 있다. 그리고, 상기 치환체들에 의해 에너지 레벨이 조절될 수 있어 넓은 밴드갭 (sky blue ~ red)을 갖게 되어 발광층뿐만 아니라, 정공 수송층, 정공 주입층 등으로도 응용될 수 있다. In particular, the compound has a broad bandgap due to an indole moiety bonded to the carbazole moiety at the terminal thereof, and has a bipolar characteristic due to various aromatic ring substituents , It is possible to exhibit excellent characteristics as a host material of the light emitting layer as compared with the conventional CBP. Thus, the phosphorescent characteristics of the device can be improved, and the hole injecting ability and / or transporting ability, luminous efficiency, driving voltage, lifetime characteristics and the like can be improved. Further, the energy level can be controlled by the above-mentioned substituents, and thus it can have a wide band gap (sky blue to red), so that it can be applied not only as a light emitting layer but also as a hole transport layer and a hole injection layer.

한편, 결합된 인돌(indole) 모이어티에 다수 도입된 다양한 방향족 환(aromatic ring) 치환체로 인해 화합물의 분자량이 유의적으로 증대됨으로써, 유리전이온도(Tg)가 향상될 수 있고, 이로 인해 종래 CBP 보다 높은 열적 안정성을 가질 수 있다. 또한, 상기 카바졸 모이어티(carbazole moiety)의 말단에 결합된 인돌(indole) 모이어티가 융합됨으로써, 화합물의 열적 안정성이 향상될 수 있을 뿐만 아니라, 상기 화학식 1의 화합물을 포함하는 유기물층의 결정화 억제에도 효과가 있다. 따라서, 본 발명에 따른 화학식 1의 화합물을 포함하는 소자는 내구성 및 수명 특성을 크게 향상시킬 수 있다. On the other hand, due to various aromatic ring substituents introduced in many of the bonded indole moieties, the molecular weight of the compound is significantly increased, so that the glass transition temperature (Tg) can be improved. As a result, It can have high thermal stability. In addition, the indole moiety bonded to the carbazole moiety may be fused to improve the thermal stability of the compound. In addition, the crystallization inhibition of the organic compound layer containing the compound of Formula 1 There is also an effect. Therefore, the device including the compound of Formula 1 according to the present invention can greatly improve durability and lifetime characteristics.

아울러, 본 발명에 따른 화학식 1의 화합물을 유기 EL 소자의 정공 주입/수송층 재료, 청색, 녹색 및/또는 적색의 인광 호스트 재료로 채택할 경우, 종래 CBP 대비 효율 및 수명 면에서 월등히 우수한 효과를 발휘할 수 있다. 따라서, 본 발명에 따른 화합물은 유기 EL 소자의 성능 개선 및 수명 향상에 크게 기여할 수 있으며, 특히 이러한 소자 수명 향상은 풀 칼라 유기 발광 패널에서의 성능 극대화에도 큰 효과가 있다.In addition, when the compound of Formula 1 according to the present invention is used as a positive hole injection / transport layer material, a blue, green and / or red phosphorescent host material of an organic EL device, it exerts an excellent effect in terms of efficiency and life . Therefore, the compound according to the present invention can greatly contribute to the improvement of the performance and lifetime of the organic EL device, and particularly the lifetime improvement of the device has a great effect for maximizing the performance in the full-color organic light emitting panel.

상기 화학식 2와 결합하여 축합고리를 형성하는 본 발명의 화학식 1의 표시되는 화합물은, 하기 화학식 3 내지 화학식 20 중 어느 하나로 표시되는 화합물로 보다 구체화될 수 있다 The compound represented by the formula (1) of the present invention which forms a condensed ring in combination with the formula (2) may be further represented by a compound represented by any one of the following formulas (3) to (20)

Figure 112012102547714-pat00003
Figure 112012102547714-pat00003

Figure 112012102547714-pat00004
Figure 112012102547714-pat00004

Figure 112012102547714-pat00005
Figure 112012102547714-pat00005

Figure 112012102547714-pat00006
Figure 112012102547714-pat00006

Figure 112012102547714-pat00007
Figure 112012102547714-pat00007

Figure 112012102547714-pat00008
Figure 112012102547714-pat00008

Figure 112012102547714-pat00009
Figure 112012102547714-pat00009

Figure 112012102547714-pat00010
Figure 112012102547714-pat00010

Figure 112012102547714-pat00011
Figure 112012102547714-pat00011

Figure 112012102547714-pat00012
Figure 112012102547714-pat00012

Figure 112012102547714-pat00013
Figure 112012102547714-pat00013

Figure 112012102547714-pat00014
Figure 112012102547714-pat00014

Figure 112012102547714-pat00015
Figure 112012102547714-pat00015

Figure 112012102547714-pat00016
Figure 112012102547714-pat00016

Figure 112012102547714-pat00017
Figure 112012102547714-pat00017

Figure 112012102547714-pat00018
Figure 112012102547714-pat00018

Figure 112012102547714-pat00019
Figure 112012102547714-pat00019

Figure 112012102547714-pat00020
Figure 112012102547714-pat00020

상기 화학식 3 내지 화학식 20 에서,In the above Chemical Formulas 3 to 20,

R1 내지 R12, X1 및 X2, Y1 및 Y2 은 상기 화학식 1에서 정의된 바와 같다.R 1 to R 12, X 1 and X 2 , Y 1 and Y 2 are as defined in the above formula (1).

보다 구체적으로, 상기 X1 및 X2는 각각 독립적으로 O, S, Se, N(Ar1) 및 C(Ar2)(Ar3)로부터 선택되고, X1 및 X2 중에서 적어도 하나는 N(Ar1)이다. 바람직하게는 X1 및 X2 모두 N(Ar1)이다. 이때 X1 및 X2가 N(Ar1)인 경우, 각각의 Ar1은 동일하거나 또는 상이하다.More specifically, X 1 and X 2 are each independently selected from O, S, Se, N (Ar 1 ) and C (Ar 2 ) (Ar 3 ), and at least one of X 1 and X 2 is N Ar 1 ). Preferably, both X 1 and X 2 are N (Ar 1 ). When X 1 and X 2 are N (Ar 1 ), each Ar 1 is the same or different.

상기 Y1 및 Y2는 각각 독립적으로 N 및 C(R13)로부터 선택되고, 바람직하게는 모두 C(R13)이다. 이때 Y1 및 Y2가 C(R13)인 경우, 각각의 R13은 동일하거나 상이하다.Y 1 and Y 2 are each independently selected from N and C (R 13 ), preferably all C (R 13 ). When Y 1 and Y 2 are C (R 13 ), each R 13 is the same or different.

또한 화학식 2와 축합고리를 비(非)형성하는 치환기, 일례로, R5와 R6, R6와 R7, 및/또는 R7과 R8 중 적어도 하나를 제외하는 R1 내지 R12는 서로 동일하거나 또는 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, C6~C40의 아릴알킬기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 및 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기, 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택되고, 이들은 인접하는 기와 결합하여 축합 고리를 형성할 수 있다. Also, R 1 to R 12 excluding at least one of R 5 and R 6 , R 6 and R 7 , and / or R 7 and R 8 substituents which form the non-forming group of the formula (2) A substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 2 to C 40 alkenyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted aryl group, a C 2 ~ C 40 of the alkynyl group, a substituted or unsubstituted C 6 ~ C 40 aryl group, a substituted or unsubstituted nuclear atoms of 5 to 40 heteroaryl group, substituted or non-substituted of unsubstituted C 6 ~ C 40 A substituted or unsubstituted C 1 to C 40 alkyloxy group, a substituted or unsubstituted C 6 to C 40 arylamine group, a C 6 to C 40 arylalkyl group, a substituted or unsubstituted C 3 ~ C 40 cycloalkyl group, a substituted or unsubstituted 3 to 40 nuclear atoms of the heterocycloalkyl group, a substituted or unsubstituted C 1 ~ C 40 alkyl silyl group, a substituted Or an unsubstituted C 1 to C 40 alkylboron group and a substituted or unsubstituted C 6 to C 40 arylboron group, a substituted or unsubstituted C 6 to C 40 arylphosphine group, a substituted or unsubstituted A C 6 to C 40 arylphosphine oxide group, and a substituted or unsubstituted C 6 to C 40 arylsilyl group, which may be bonded to adjacent groups to form a condensed ring.

본 발명에서, 상기 R1 내지 R12, 및 R13 은 수소, 중수소(D), 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 및 치환 또는 비치환된 C6~C40의 아릴아민기로 이루어진 군에서 선택되는 것이 바람직하다. In the present invention, R 1 to R 12 and R 13 are each independently selected from the group consisting of hydrogen, deuterium (D), a substituted or unsubstituted C 6 to C 40 aryl group, a substituted or unsubstituted heteroaryl And a substituted or unsubstituted C 6 to C 40 arylamine group.

상기 Ar1 내지 Ar3는 서로 동일하거나 또는 상이하며, 각각 독립적으로 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C2~C40의 알케닐기, 치환 또는 비치환된 C2~C40의 알키닐기, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 치환 또는 비치환된 C6~C40의 아릴옥시기, 치환 또는 비치환된 C1~C40의 알킬옥시기, 치환 또는 비치환된 C6~C40의 아릴아민기, C6~C40의 아릴알킬기, 치환 또는 비치환된 C3~C40의 시클로알킬기, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로시클로알킬기, 치환 또는 비치환된 C1~C40의 알킬실릴기, 치환 또는 비치환된 C1~C40의 알킬보론기, 및 치환 또는 비치환된 C6~C40의 아릴보론기, 치환 또는 비치환된 C6~C40의 아릴포스핀기, 치환 또는 비치환된 C6~C40의 아릴포스핀옥사이드기 및 치환 또는 비치환된 C6~C40의 아릴실릴기로 이루어진 군에서 선택된다. Wherein Ar 1 to Ar 3 are the same or different and each independently represents a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 2 to C 40 alkenyl group, a substituted or unsubstituted C of 2 ~ C 40 alkynyl group, a substituted or unsubstituted C 6 ~ C 40 aryl group, a substituted or unsubstituted nuclear atoms of 5 to 40 heteroaryl group, a substituted or unsubstituted in the ring C 6 ~ C 40 aryl Substituted or unsubstituted C 1 to C 40 alkyloxy groups, substituted or unsubstituted C 6 to C 40 arylamine groups, C 6 to C 40 arylalkyl groups, substituted or unsubstituted C 3 to C 40 arylalkyl groups, C 40 cycloalkyl group, a substituted or unsubstituted nuclear atoms of 3 to 40 heterocycloalkyl group, a substituted or unsubstituted C 1 ~ C 40 alkyl silyl group, a substituted or unsubstituted C alkyl boron of 1 ~ C 40 And a substituted or unsubstituted C 6 to C 40 arylboron group, a substituted or unsubstituted C 6 to C 40 arylphosphine group, a substituted or unsubstituted A C 6 to C 40 arylphosphine oxide group, and a substituted or unsubstituted C 6 to C 40 arylsilyl group.

본 발명에서, Ar1 내지 Ar3는 치환 또는 비치환된 C6~C40의 아릴기 및 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군으로부터 선택되는 것이 바람직하다. In the present invention, Ar 1 to Ar 3 are preferably selected from the group consisting of a substituted or unsubstituted C 6 to C 40 aryl group and a substituted or unsubstituted heteroaryl group having 5 to 40 nucleus atoms.

여기서, 상기 R1 내지 R13, Ar1 내지 Ar3의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 아릴알킬기, 시클로알킬기, 헤테로시클로알킬기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C6~C40의 아릴알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 아릴포스핀옥사이드기 및 C6~C40의 아릴실릴기로 이루어진 군으로부터 선택되는 하나 이상의 치환기로 치환될 수 있으며, 이때 복수개의 치환기가 치환되는 경우, 이들은 서로 동일하거나 상이하다.Here, the alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, arylamine group, arylalkyl group, cycloalkyl group, heterocycloalkyl group of R 1 to R 13 and Ar 1 to Ar 3 , alkyl group, an alkylsilyl group, an alkyl boron group, an aryl boron group, an aryl phosphine group, aryl phosphine oxide group and an aryl silyl group each independently selected from deuterium, halogen, cyano, C alkyl group of 1 ~ C 40, C 2 ~ C 40 A C 2 to C 40 alkynyl group, a C 6 to C 40 aryl group, a heteroaryl group having 5 to 40 nuclear atoms, a C 6 to C 40 aryloxy group, a C 1 to C 40 alkyl oxy group, C 6 ~ C 40 aryl amine group, C 6 ~ C 40 aryl group, C 3 ~ C 40 cycloalkyl group, a number of nuclear atoms of 3 to 40 heterocycloalkyl group, C 1 ~ C 40 alkyl silyl of the group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C 40 aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 aryl phosphine oxide group, and a C 6 ~ C 40 of Arylsilyl Which may be substituted with one or more substituents selected from the group consisting of, wherein if a plurality of substituents substituted, which are the same or different from each other.

본 발명의 화학식 1로 표시되는 화합물에서, X1 및 X2가 N(Ar1)이고, Y1 및 Y2가 C(R13)인 경우, 하기 화학식 21 내지 화학식 38 중 어느 하나로 표시되는 화합물로 보다 구체화될 수 있다.In the compound represented by the formula (1) of the present invention, when X 1 and X 2 are N (Ar 1 ) and Y 1 and Y 2 are C (R 13 ), a compound represented by any one of the following formulas As shown in FIG.

Figure 112012102547714-pat00021
Figure 112012102547714-pat00021

Figure 112012102547714-pat00022
Figure 112012102547714-pat00022

Figure 112012102547714-pat00023
Figure 112012102547714-pat00023

Figure 112012102547714-pat00024
Figure 112012102547714-pat00024

Figure 112012102547714-pat00025
Figure 112012102547714-pat00025

Figure 112012102547714-pat00026
Figure 112012102547714-pat00026

Figure 112012102547714-pat00027
Figure 112012102547714-pat00027

Figure 112012102547714-pat00028
Figure 112012102547714-pat00028

Figure 112012102547714-pat00029
Figure 112012102547714-pat00029

Figure 112012102547714-pat00030
Figure 112012102547714-pat00030

Figure 112012102547714-pat00031
Figure 112012102547714-pat00031

Figure 112012102547714-pat00032
Figure 112012102547714-pat00032

Figure 112012102547714-pat00033
Figure 112012102547714-pat00033

Figure 112012102547714-pat00034
Figure 112012102547714-pat00034

Figure 112012102547714-pat00035
Figure 112012102547714-pat00035

Figure 112012102547714-pat00036
Figure 112012102547714-pat00036

Figure 112012102547714-pat00037
Figure 112012102547714-pat00037

Figure 112012102547714-pat00038
Figure 112012102547714-pat00038

상기 화학식 21 내지 화학식 38 에서, In the above Formulas 21 to 38,

R1 내지 R13 및 Ar1 은 각각 제1항에서 정의한 바와 동일하다.R 1 to R 13 and Ar 1 are the same as defined in claim 1 , respectively.

보다 구체적으로, 상기 R1 내지 R12, 및 R13 은 수소, 중수소, 치환 또는 비치환된 C6~C40의 아릴기, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기, 및 치환 또는 비치환된 C6~C40의 아릴아민기로 이루어진 군에서 선택되는 것이 바람직하다.More specifically, R 1 to R 12 and R 13 are selected from the group consisting of hydrogen, deuterium, a substituted or unsubstituted C 6 to C 40 aryl group, a substituted or unsubstituted heteroaryl group having 5 to 40 nucleus atoms, and And a substituted or unsubstituted C 6 to C 40 arylamine group.

또한 Ar1 은 치환 또는 비치환된 C6~C40의 아릴기 및 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군으로부터 선택되는 것이 바람직하다.It is preferable that Ar 1 is selected from the group consisting of a substituted or unsubstituted C 6 to C 40 aryl group and a substituted or unsubstituted heteroaryl group having 5 to 40 nucleus atoms.

본 발명에 따른 화학식 1로 표시되는 화합물에서, R1 내지 R13 및 Ar1 내지 Ar3 는 각각 독립적으로 수소, 또는 하기 치환기 S1 내지 S196으로 이루어진 치환체 군에서 선택되는 것이 보다 바람직하다. 그러나 이에 한정되는 것은 아니다. In the compound represented by formula (1) according to the present invention, R 1 to R 13 and Ar 1 to Ar 3 are each independently hydrogen or more preferably selected from the group consisting of substituents S1 to S196 shown below. However, the present invention is not limited thereto.

Figure 112012102547714-pat00039
Figure 112012102547714-pat00039

Figure 112012102547714-pat00040
Figure 112012102547714-pat00040

Figure 112012102547714-pat00041
Figure 112012102547714-pat00041

더욱 바람직하게는 Ar1 내지 Ar3 는 하기 치환체 군에서 선택될 수 있다.More preferably Ar 1 to Ar 3 may be selected from the following substituent groups.

Figure 112012102547714-pat00042
Figure 112012102547714-pat00042

이상에서 설명한 본 발명의 화합물은 하기 예시된 구조들로 보다 구체화될 수 있다. 그러나 본 발명의 화학식 1로 표시되는 화합물이 하기 예시된 것들에 의해 한정되는 것은 아니다.The compounds of the present invention described above can be further exemplified by the following exemplified structures. However, the compounds represented by formula (1) of the present invention are not limited by the following examples.

Figure 112012102547714-pat00043
Figure 112012102547714-pat00043

Figure 112012102547714-pat00044
Figure 112012102547714-pat00044

Figure 112012102547714-pat00045
Figure 112012102547714-pat00045

Figure 112012102547714-pat00046
Figure 112012102547714-pat00046

Figure 112012102547714-pat00047
Figure 112012102547714-pat00047

Figure 112012102547714-pat00048
Figure 112012102547714-pat00048

Figure 112012102547714-pat00049
Figure 112012102547714-pat00049

Figure 112012102547714-pat00050
Figure 112012102547714-pat00050

Figure 112012102547714-pat00051
Figure 112012102547714-pat00051

Figure 112012102547714-pat00052
Figure 112012102547714-pat00052

Figure 112012102547714-pat00053
Figure 112012102547714-pat00053

Figure 112012102547714-pat00054
Figure 112012102547714-pat00054

Figure 112012102547714-pat00055
Figure 112012102547714-pat00055

Figure 112012102547714-pat00056
Figure 112012102547714-pat00056

Figure 112012102547714-pat00057
Figure 112012102547714-pat00057

Figure 112012102547714-pat00058
Figure 112012102547714-pat00058

Figure 112012102547714-pat00059
Figure 112012102547714-pat00059

Figure 112012102547714-pat00060
Figure 112012102547714-pat00060

Figure 112012102547714-pat00061
Figure 112012102547714-pat00061

Figure 112012102547714-pat00062
Figure 112012102547714-pat00062

Figure 112012102547714-pat00063
Figure 112012102547714-pat00063

Figure 112012102547714-pat00064
Figure 112012102547714-pat00064

Figure 112012102547714-pat00065
Figure 112012102547714-pat00065

Figure 112012102547714-pat00066
Figure 112012102547714-pat00066

Figure 112012102547714-pat00067
Figure 112012102547714-pat00067

Figure 112012102547714-pat00068
Figure 112012102547714-pat00068

Figure 112012102547714-pat00069

Figure 112012102547714-pat00069

본 발명에서 사용된 "비치환된 알킬"은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 포함한다. As used herein, "unsubstituted alkyl" is a monovalent substituent derived from a straight or branched saturated hydrocarbon having 1 to 40 carbon atoms, and examples thereof include methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso -Amyl, hexyl, and the like.

"비치환된 알케닐(alkenyl)"은 탄소-탄소 이중 결합을 1개 이상 가진, 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등이 있으며, 이에 한정되는 것은 아니다. "Unsubstituted alkenyl" is a monovalent substituent derived from a straight or branched unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon double bond. Examples thereof include vinyl, allyl, but are not limited to, allyl, isopropenyl, 2-butenyl, and the like.

"비치환된 알키닐(alkynyl)"은 탄소-탄소 삼중 결합을 1개 이상 가진, 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 에타인일(ethynyl), 2-프로파인일(2-propynyl) 등이 있는데, 이에 제한되는 것은 아니다."Unsubstituted alkynyl" is a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon triple bond. Examples thereof include ethynyl, , 2-propynyl, and the like, but are not limited thereto.

"비치환된 아릴"은 단독 고리 또는 2 이상의 고리가 조합된, 탄소수 6 내지 60의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태로 부착될 수 있다. 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등이 포함되며, 이에 한정되는 것은 아니다."Unsubstituted aryl" means a monovalent substituent derived from an aromatic hydrocarbon having 6 to 60 carbon atoms, either alone or in combination with at least two rings. Two or more rings may be attached to each other in a pendant or condensed form. Examples of aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.

"비치환된 헤테로아릴"은 핵원자수 5 내지 40의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태로 부착될 수 있고, 나아가 아릴기와의 축합된 형태도 포함하는 것으로 해석한다. 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리를 포함하고, 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등도 포함하는 것으로 해석한다."Unsubstituted heteroaryl" means a monovalent substituent derived from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 40 nuclear atoms. One or more carbons, preferably one to three carbons, of the ring are substituted with a heteroatom such as N, O, S or Se. It is interpreted that two or more rings may be attached to each other in a pendant or condensed form together with a condensed form with an aryl group. Examples of heteroaryl include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, and triazinyl; Such as phenoxathienyl, indolizinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl, and the like. Includes rings and is also meant to include 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl and the like.

"비치환된 아릴옥시"는 RO-로 표시되는 1가의 치환기로서, 상기 R은 탄소수 5 내지 60의 아릴이다. 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등이 있다."Unsubstituted aryloxy" is a monovalent substituent represented by RO-, wherein R is aryl having 5 to 60 carbon atoms. Examples of aryloxy include phenyloxy, naphthyloxy, diphenyloxy, and the like.

"비치환된 알킬옥시"는 R'O-로 표시되는 1가의 치환기로서, 상기 R'는 1 내지 40개의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함하는 것으로 해석한다. 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등이 포함될 수 있으며 이에 한정되지는 않는다. "Unsubstituted alkyloxy" means a monovalent substituent group represented by R'O-, wherein R 'represents an alkyl having 1 to 40 carbon atoms, and may have a linear, branched or cyclic structure . Examples of alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.

"비치환된 아릴아민"은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다."Unsubstituted arylamine" means an amine substituted with aryl having 6 to 60 carbon atoms.

"비치환된 시클로알킬"은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 놀보닐(norbornyl), 아다만틴(adamantine)등이 포함되지만 이에 한정되는 것은 아니다. "Unsubstituted cycloalkyl" means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having from 3 to 40 carbon atoms. Examples of such cycloalkyls include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.

"비치환된 헤테로시클로알킬"은 핵원자수 3 내지 40의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O 또는 S와 같은 헤테로 원자로 치환된다. 이의 비-제한적인 예로는 모르폴린, 피페라진 등이 있다."Unsubstituted heterocycloalkyl" means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, wherein at least one of the carbons, preferably one to three carbons, is replaced by N, O, or S Lt; / RTI &gt; Non-limiting examples thereof include morpholine, piperazine, and the like.

"알킬실릴"은 탄소수 1 내지 40의 알킬로 치환된 실릴이고, "아릴실릴"은 탄소수 5 내지 40의 아릴로 치환된 실릴을 의미한다."Alkylsilyl" is silyl substituted with alkyl having 1 to 40 carbon atoms, and "arylsilyl" means silyl substituted with aryl having 5 to 40 carbon atoms.

"축합고리"는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다."Condensation ring" means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.

본 발명의 화학식 1의 화합물은 일반적인 합성방법에 따라 합성될 수 있다(Chem. Rev., 60:313 (1960); J. Chem. SOC. 4482 (1955); Chem. Rev. 95: 2457 (1995) 등 참조). 본 발명의 화합물에 대한 상세한 합성 과정은 후술하는 합성예에서 구체적으로 기술하도록 한다. The compounds of formula 1 of the present invention can be synthesized according to the general synthetic methods ( Chem. Rev. , 60 : 313 (1960); J. Chem. SOC . 4482 (1955); Chem. Rev. 95: 2457 (1995 ). Detailed synthesis of the compound of the present invention will be described in detail in Synthesis Examples to be described later.

<유기 전계 발광 소자>&Lt; Organic electroluminescent device &

한편, 본 발명의 다른 측면은 상기한 본 발명에 따른 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자에 관한 것이다. According to another aspect of the present invention, there is provided an organic electroluminescent device comprising the compound represented by Formula 1 according to the present invention.

구체적으로, 본 발명의 유기 전계 발광 소자는 양극, 음극, 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물, 바람직하게는 화학식 3으로 표시되는 화합물 내지 화학식 20으로 표시되는 화합물, 보다 바람직하게는 화학식 21 내지 화학식 38로 표시되는 화합물 중 어느 하나를 포함한다. 이때, 상기 화학식 3 내지 20의 화합물은 단독으로 또는 2 이상이 혼합되어 사용될 수 있다.Specifically, the organic electroluminescent device of the present invention includes a cathode, a cathode, and at least one organic layer sandwiched between the anode and the cathode, wherein at least one of the one or more organic layers is represented by Formula 1 Compound, preferably a compound represented by the general formula (3) to a compound represented by the general formula (20), more preferably any one of the compounds represented by the general formulas (21) to (38). At this time, the compounds of formulas (3) to (20) may be used singly or in combination of two or more.

상기 1층 이상의 유기물층은 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 어느 하나 이상일 수 있고, 이 중에서 적어도 하나의 유기물층이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 바람직하게는 상기 화합물 1의 화합물을 포함하는 유기물층은 발광층일 수 있다.The one or more organic layers may be at least one of a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer, and at least one organic layer may include a compound represented by Formula 1. Preferably, the organic compound layer containing the compound of Compound 1 may be an emissive layer.

본 발명의 일례에 따르면, 유기 전계 발광 소자의 발광층은 호스트 재료를 포함할 수 있는데, 이때 호스트 재료로서 상기 화학식 1의 화합물을 포함할 수 있다. 이와 같이, 상기 화학식 1의 화합물을 유기 전계 발광 소자의 발광층 재료, 바람직하게는 청색, 녹색, 적색의 인광 호스트로 포함할 경우, 발광층에서 정공과 전자의 결합력이 높아지기 때문에, 유기 전계 발광 소자의 효율(발광효율 및 전력효율), 수명, 휘도 및 구동전압 등이 향상될 수 있다. 상기 화학식 1로 표시되는 화합물은 청색, 녹색 및/또는 적색의 인광 호스트, 형광 호스트, 또는 도펀트 재료로서 유기 발광 소자에 포함될 수 있다. According to an embodiment of the present invention, the light emitting layer of the organic electroluminescent device may include a host material, and the host material may include the compound of the above formula (1). Thus, when the compound of Formula 1 is incorporated into a light emitting layer material of an organic electroluminescent device, preferably a blue, green, or red phosphorescent host, the bonding strength between holes and electrons in the light emitting layer is increased. (Luminous efficiency and power efficiency), lifetime, luminance, driving voltage, and the like can be improved. The compound represented by Formula 1 may be included in an organic light emitting device as a blue, green, and / or red phosphorescent host, a fluorescent host, or a dopant material.

전술한 본 발명에 따른 유기 전계 발광 소자의 구조는 특별히 한정되지 않으며, 예컨대 기판, 양극, 정공주입층, 정공수송층, 발광층, 전자수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 이때, 상기 정공주입층, 정공수송층, 발광층, 전자수송층 및 전자주입층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있고, 바람직하게는 발광층이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 이때, 본 발명의 화합물은 발광층의 인광 호스트로 이용될 수 있다. 상기 전자수송층 위에는 전자주입층이 추가로 적층될 수 있다. The structure of the organic electroluminescent device according to the present invention is not particularly limited and may be a structure in which a substrate, an anode, a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and a cathode are sequentially stacked. At least one of the hole injecting layer, the hole transporting layer, the light emitting layer, the electron transporting layer, and the electron injecting layer may include a compound represented by Formula 1, and preferably, the emitting layer includes a compound represented by Formula 1 . At this time, the compound of the present invention can be used as a phosphorescent host of the light emitting layer. An electron injection layer may be further stacked on the electron transport layer.

또한, 본 발명에 따른 유기 전계 발광 소자의 구조는 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층될 뿐만 아니라, 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수 있다.In addition, the structure of the organic electroluminescent device according to the present invention may be a structure in which an anode, one or more organic layers and an anode are sequentially laminated, and an insulating layer or an adhesive layer is inserted into the interface between the electrode and the organic layer.

본 발명에 따른 유기 전계 발광 소자는 상기 유기물층 중 1층 이상(예컨대, 발광층)이 상기 화학식 1로 표시되는 화합물을 포함하도록 형성하는 것을 제외하고는, 당 기술 분야에 알려져 있는 재료 및 방법을 이용하여 다른 유기물층 및 전극을 형성하여 제조될 수 있다.The organic electroluminescent device according to the present invention may be formed by using materials and methods known in the art, except that at least one layer (for example, a light emitting layer) of the organic material layer includes the compound represented by Formula 1 Other organic material layers and electrodes.

상기 유기물층은 진공 증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이들에 한정되지 않는다.The organic material layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.

본 발명에서 사용 가능한 기판으로는 특별히 한정되지 않으며, 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 및 시트 등이 사용될 수 있다.The substrate usable in the present invention is not particularly limited, and a silicon wafer, quartz, a glass plate, a metal plate, a plastic film and a sheet can be used.

또, 사용 가능한 양극 물질의 비제한적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등이 있는데, 이에 한정되지 않는다.Non-limiting examples of usable cathode materials include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole or polyaniline; And carbon black, but are not limited thereto.

또, 사용 가능한 음극 물질의 비제한적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있는데, 이에 한정되지 않는다.Non-limiting examples of usable cathode materials include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin or lead or alloys thereof; And multi-layer structure materials such as LiF / Al or LiO 2 / Al, but are not limited thereto.

또한, 정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층은 특별히 한정되는 것은 아니며, 당 업계에 알려진 통상의 물질이 사용될 수 있다.The hole injecting layer, the hole transporting layer, the electron injecting layer and the electron transporting layer are not particularly limited, and conventional materials known in the art can be used.

이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are illustrative of the present invention, and the present invention is not limited by the following examples.

[준비예 1] IC-1의 합성[Preparation Example 1] Synthesis of IC-1

<단계 1> 6-bromo-1H-benzo[g]indole의 합성<Step 1> Synthesis of 6-bromo-1H-benzo [g] indole

Figure 112012102547714-pat00070
Figure 112012102547714-pat00070

질소 기류 하에서 1-bromo-5-nitronaphthalene (20 g, 79.35 mmol)을 800 ml THF에 녹인 후 -40℃로 내리고 vinylmagnesium bromide (31.24 g, 238.04 mmol)을 넣었다. 20분 교반 후 포화된 NH4Cl 수용액을 사용하여 반응을 종결시킨 후 에틸아세테이트로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane : MC = 5:1 (v/v))로 정제하여 6-bromo-1H-benzo[g]indole (12.69 g, 수율 65 %)을 얻었다. 1-Bromo-5-nitronaphthalene (20 g, 79.35 mmol) was dissolved in 800 ml of THF under a nitrogen stream and then cooled to -40 ° C and vinylmagnesium bromide (31.24 g, 238.04 mmol) was added. Using MgSO 4 to remove water and the organic layer was separated with ethyl acetate After completion of the reaction by using a saturated aqueous solution of NH4Cl and then stirred for 20 minutes. The solvent was removed from the organic layer from which water had been removed and then purified by column chromatography (Hexane: MC = 5: 1 (v / v)) to obtain 6-bromo-1H- benzo [g] indole (12.69 g, yield 65% .

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.46 (t, 1H), 7.57 (d, 1H), 7.97 (d, 1H), 8.12 (d, 2H), 10.14 (s, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.46 (t, 1H), 7.57 (d, 1H), 7.97 (d, 1H), 8.12 (d, 2H), 10.14 ( s, 1 H)

<단계 2> 6-(2-nitrophenyl)-1H-benzo[g]indole의 합성<Step 2> Synthesis of 6- (2-nitrophenyl) -1H-benzo [g] indole

Figure 112012102547714-pat00071
Figure 112012102547714-pat00071

질소 기류 하에서 6-bromo-1H-benzo[g]indole (12 g, 48.76 mmol)과 2-nitrophenylboronic acid (9.77 g, 58.51 mmol), K2CO3 (20.22 g, 146.28 mmol) 및 THF/H2O(300 ml/150 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(2.82 g, 5 mol%)를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane : EA = 5:1 (v/v))로 정제하여 목적 화합물인 6-(2-nitrophenyl)-1H-benzo[g]indole (11.53 g, 82 %)를 얻었다. 6-bromo-1H-benzo [ g] indole (12 g, 48.76 mmol) and 2-nitrophenylboronic acid (9.77 g, 58.51 mmol), K 2 CO 3 (20.22 g, 146.28 mmol) and THF / H 2 in a nitrogen atmosphere O a mixture (300 ml / 150 ml), then insert the Pd (PPh 3) 4 (2.82 g, 5 mol%) at 40 ℃ was stirred at 80 ℃ for 12 hours. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and the residue was purified by column chromatography (Hexane: EA = 5: 1 (v / v)) to obtain 6- (2-nitrophenyl) -1H-benzo [g] indole (11.53 g, 82 %).

1H-NMR: δ 6.44 (d, 1H), 7.26 (d, 1H), 7.45 (t, 1H), 7.56 (d, 1H), 7.67 (t, 1H), 7.91 (t, 1H), 8.01 (m, 2H), 8.10 (m, 3H), 10.18 (s, 1H)
1 H-NMR: δ 6.44 ( d, 1H), 7.26 (d, 1H), 7.45 (t, 1H), 7.56 (d, 1H), 7.67 (t, 1H), 7.91 (t, 1H), 8.01 ( m, 2H), 8.10 (m, 3H), 10.18 (s, 1H)

<단계 3> 6-(2-&Lt; Step 3 > 6- (2- nitrophenylnitrophenyl )-1-)-One- phenylphenyl -1H--1H- benzobenzo [g]indole의 합성Synthesis of [g] indole

Figure 112012102547714-pat00072
Figure 112012102547714-pat00072

질소 기류 하에서 6-(2-nitrophenyl)-1H-benzo[g]indole (11 g, 38.15 mmol), iodobenzene (11.68 g, 57.23 mmol), Cu powder (0.24 g, 3.82 mmol), K2CO3 (5.27 g, 38.15 mmol), Na2SO4 (5.42 g, 38.15 mmol), nitrobenzene (200 ml)를 혼합하고 200℃에서 24시간 동안 교반하였다. 반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane : MC = 1:1 (v/v))로 정제하여 6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole (7.09 g, 수율 51 %)을 얻었다. Iodobenzene (11.68 g, 57.23 mmol), Cu powder (0.24 g, 3.82 mmol), and K 2 CO 3 (11 g, 38.15 mmol) were added to a solution of 6- (2-nitrophenyl) 5.27 g, 38.15 mmol), Na 2 SO 4 (5.42 g, 38.15 mmol) and nitrobenzene (200 ml) were mixed and stirred at 200 ° C for 24 hours. After completion of the reaction, the nitrobenzene was removed. The organic layer was separated with methylene chloride, and water was removed using MgSO 4 . After removing the solvent from the organic layer from which water had been removed, the residue was purified by column chromatography (Hexane: MC = 1: 1 (v / v)) to obtain 6- (2-nitrophenyl) 7.09 g, yield: 51%).

1H-NMR: δ 6.43 (d, 1H), 7.28 (d, 1H), 7.43 (m, 2H), 7.50 (d, 2H), 7.58 (m, 3H), 7.66 (t, 1H), 7.90 (t, 1H), 8.00 (m, 2H), 8.13 (m, 3H)
1 H-NMR: δ 6.43 ( d, 1H), 7.28 (d, 1H), 7.43 (m, 2H), 7.50 (d, 2H), 7.58 (m, 3H), 7.66 (t, 1H), 7.90 ( t, 1 H), 8.00 (m, 2 H), 8.13 (m, 3 H)

<단계 4> IC-1의 합성<Step 4> Synthesis of IC-1

Figure 112012102547714-pat00073
Figure 112012102547714-pat00073

질소 기류 하에서 상기 6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole (7 g, 19.46 mmol), triphenylphosphine (12.76 g, 48.64 mmol) 및 1,2-dichlorobenzene (100 ml)를 혼합하고 12시간 동안 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 얻어진 유기층에 대해 MgSO4로 물을 제거하고, 컬럼크로마토그래피 (Hexane : MC=2:1 (v/v))로 정제하여 IC-1 (3.04 g, 수율 47%)을 얻었다. Indole (7 g, 19.46 mmol), triphenylphosphine (12.76 g, 48.64 mmol), and 1,2-dichlorobenzene (100 ml) were added to a solution of 6- (2-nitrophenyl) The mixture was stirred for 12 hours. After completion of the reaction, 1,2-dichlorobenzene was removed and extracted with dichloromethane. Water was removed from the obtained organic layer with MgSO 4 and purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain IC-1 (3.04 g, yield 47%).

1H-NMR: δ 6.45 (d, 1H), 7.30 (d, 1H), 7.44 (m, 2H), 7.52 (d, 2H), 7.59 (m, 3H), 7.69 (t, 1H), 7.91 (t, 1H), 8.02 (m, 2H), 8.14 (m, 2H), 10.15 (s, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.30 (d, 1H), 7.44 (m, 2H), 7.52 (d, 2H), 7.59 (m, 3H), 7.69 (t, 1H), 7.91 ( 1H), 8.02 (m, 2H), 8.14 (m, 2H), 10.15

[준비예 2] IC-2의 합성[Preparation Example 2] Synthesis of IC-2

<단계 1> 2-bromo-6-(2-nitrophenyl)naphthalene의 합성<Step 1> Synthesis of 2-bromo-6- (2-nitrophenyl) naphthalene

Figure 112012102547714-pat00074
Figure 112012102547714-pat00074

2,6-dibromonaphthalene (30 g, 104.91 mmol), 2-nitrophenylboronic acid (21.02 g, 125.89 mmol), Pd(PPh3)4(6.06 g, 5 mol%), K2CO3 (43.50 g, 314.73 mmol) 및 THF/H2O(500 ml/200 ml)를 사용하여 상기 준비예 1의 <단계 2>와 동일한 방법으로, 목적 화합물인 2-bromo-6-(2-nitrophenyl)naphthalene (22.03 g, 수율 64 %)를 획득하였다.2,6-dibromonaphthalene (30 g, 104.91 mmol), 2-nitrophenylboronic acid (21.02 g, 125.89 mmol), Pd (PPh 3) 4 (6.06 g, 5 mol%), K 2 CO 3 (43.50 g, 314.73 mmol ) and THF / H 2 O (500 ml / 200 ml) using the same procedure as in <step 2> the preparation example 1, the desired compound of 2-bromo-6- (2- nitrophenyl) naphthalene (22.03 g, Yield 64%).

1H-NMR: δ 7.46 (d, 1H), 7.51 (s, 1H), 7.67 (t, 1H), 7.80 (d, 1H), 7.91 (m, 3H), 8.03 (m, 2H), 8.21 (s, 1H)
1 H-NMR: δ 7.46 ( d, 1H), 7.51 (s, 1H), 7.67 (t, 1H), 7.80 (d, 1H), 7.91 (m, 3H), 8.03 (m, 2H), 8.21 ( s, 1 H)

<단계 2> 6-(2-nitrophenyl)naphthalen-2-amine의 합성<Step 2> Synthesis of 6- (2-nitrophenyl) naphthalen-2-amine

Figure 112012102547714-pat00075
Figure 112012102547714-pat00075

질소 기류 하에서 2-bromo-6-(2-nitrophenyl)naphthalene (22 g, 67.04 mmol)을 THF 250 ml 에 녹인 후, aqueous ammonia (22.8 ml, 335.2 mmol) 과 Cu (0.21 g, 5 mol%)를 넣고, 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터링하였다. 필터링된 유기층의 용매를 제거한 후 컬럼크로마토그래피 (Hexane : EA=5:1 (v/v))로 정제하여 6-(2-nitrophenyl)naphthalen-2-amine (14.17 g, 수율 80%)을 획득하였다.Aqueous ammonia (22.8 ml, 335.2 mmol) and Cu (0.21 g, 5 mol%) were dissolved in 250 ml of THF under a nitrogen atmosphere. , And the mixture was stirred at 110 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . The solvent was removed from the filtered organic layer and the residue was purified by column chromatography (hexane: EA = 5: 1 (v / v)) to obtain 6- (2-nitrophenyl) naphthalen-2-amine (14.17 g, yield 80% Respectively.

1H-NMR: δ 4.62 (s, 2H), 7.47 (d, 1H), 7.52 (s, 1H), 7.66 (t, 1H), 7.74 (s, 1H), 7.82 (d, 1H), 7.92 (m, 3H), 8.02 (m, 2H)
1 H-NMR: δ 4.62 ( s, 2H), 7.47 (d, 1H), 7.52 (s, 1H), 7.66 (t, 1H), 7.74 (s, 1H), 7.82 (d, 1H), 7.92 ( m, 3 H), 8.02 (m, 2 H)

<단계 3> 7-(2-nitrophenyl)-3H-benzo[e]indole의 합성<Step 3> Synthesis of 7- (2-nitrophenyl) -3H-benzo [e] indole

Figure 112012102547714-pat00076
Figure 112012102547714-pat00076

질소 기류 하에서 9-phenyl-9H-carbazol-2-amine (14 g, 52.97 mmol)을 H2O/dioxane (10 ml / 90 ml) 에 녹인 후, triethanolammonium chloride (0.98 g, 5.30 mmol) 과 RuCl3`H2O (0.12 g, 0.5 mmol)과 PPh3 (0.42 g, 1.59 mmol), SnCl2`2H2O (1.20 g, 5.30 mmol)을 넣고, 180℃에서 20시간 동안 교반하였다. 반응 종결 후 aqueous 5% HCl 에 반응물을 붓고, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피(Hexane : EA=5:1 (v/v))로 정제하여 7-(2-nitrophenyl)-3H-benzo[e]indole (7.94 g, 수율 52%)을 얻었다.(14 g, 52.97 mmol) was dissolved in H 2 O / dioxane (10 ml / 90 ml), and triethanolammonium chloride (0.98 g, 5.30 mmol) and RuCl 3 put the `H 2 O (0.12 g, 0.5 mmol) and PPh 3 (0.42 g, 1.59 mmol ), SnCl 2` 2H 2 O (1.20 g, 5.30 mmol), and stirred at 180 ℃ for 20 hours. After the reaction was completed, the reaction mixture was poured into aqueous 5% HCl, extracted with methylene chloride, and charged with MgSO 4 . After removing the solvent of the filtered organic layer, the residue was purified by column chromatography (Hexane: EA = 5: 1 (v / v)) to obtain 7- (2-nitrophenyl) -3H- ).

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.58 (s, 1H), 7.65 (m, 3H), 7.73 (d, 1H), 7.90 (t, 1H), 8.00 (d, 1H), 8.05 (m, 2H), 10.20 (s, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.58 (s, 1H), 7.65 (m, 3H), 7.73 (d, 1H), 7.90 (t, 1H), 8.00 ( d, 1 H), 8.05 (m, 2H), 10.20 (s, 1 H)

<단계 4> 7-(2-nitrophenyl)-3-phenyl-3H-benzo[e]indole의 합성<Step 4> Synthesis of 7- (2-nitrophenyl) -3-phenyl-3H-benzo [e] indole

Figure 112012102547714-pat00077
Figure 112012102547714-pat00077

6-(2-nitrophenyl)-1H-benzo[g]indole 대신 7-(2-nitrophenyl)-3H-benzo[e]indole을 사용하는 것을 제외하고는, 상기 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 7-(2-nitrophenyl)-3-phenyl-3H-benzo[e]indole을 얻었다.Step 3> of Preparation Example 1 was repeated except that 7- (2-nitrophenyl) -3H-benzo [e] indole was used instead of 6- (2-nitrophenyl) The same procedure was followed to obtain 7- (2-nitrophenyl) -3-phenyl-3H-benzo [e] indole.

1H-NMR: δ 6.44 (d, 1H), 7.26 (d, 1H), 7.46 (m, 1H), 7.51 (d, 2H), 7.59 (m, 3H), 7.66 (m, 3H), 7.72 (d, 1H), 7.91 (t, 1H), 8.01 (d, 1H), 8.07 (m, 2H)
1 H-NMR: δ 6.44 ( d, 1H), 7.26 (d, 1H), 7.46 (m, 1H), 7.51 (d, 2H), 7.59 (m, 3H), 7.66 (m, 3H), 7.72 ( (d, IH), 7.91 (t, IH), 8.01 (d, IH), 8.07

<단계 5> IC-2의 합성<Step 5> Synthesis of IC-2

Figure 112012102547714-pat00078
Figure 112012102547714-pat00078

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 7-(2-nitrophenyl)-3-phenyl-3H-benzo[e]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-2를 얻었다.Except that 7- (2-nitrophenyl) -3-phenyl-3H-benzo [e] indole was used in place of 6- (2-nitrophenyl) -1-phenyl- IC-2 was obtained by performing the same procedure as < Step 4 >.

1H-NMR: δ 6.45 (d, 1H), 7.25 (d, 1H), 7.47 (m, 1H), 7.52 (m, 3H), 7.58 (m, 2H), 7.65 (m, 3H), 7.92 (t, 1H), 8.02 (d, 1H), 8.09 (m, 2H), 11.70 (s, 1H).
1 H-NMR: δ 6.45 ( d, 1H), 7.25 (d, 1H), 7.47 (m, 1H), 7.52 (m, 3H), 7.58 (m, 2H), 7.65 (m, 3H), 7.92 ( t, 1 H), 8.02 (d, 1 H), 8.09 (m, 2 H), 11.70 (s, 1 H).

[준비예 3] IC-3의 합성[Preparation Example 3] Synthesis of IC-3

Figure 112012102547714-pat00079
Figure 112012102547714-pat00079

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 7-(2-nitrophenyl)-3-phenyl-3H-benzo[e]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-3를 얻었다.Except that 7- (2-nitrophenyl) -3-phenyl-3H-benzo [e] indole was used in place of 6- (2-nitrophenyl) -1-phenyl- IC-3 was obtained by carrying out the same procedure as < Step 4 >

1H-NMR: δ 6.46 (d, 1H), 7.26 (d, 1H), 7.46 (m, 1H), 7.51 (d, 2H), 7.57 (m, 2H), 7.64 (m, 3H), 7.91 (t, 1H), 8.00 (d, 1H), 8.08 (m, 2H), 8.12 (d, 1H), 11.72 (s, 1H)
1 H-NMR: δ 6.46 ( d, 1H), 7.26 (d, 1H), 7.46 (m, 1H), 7.51 (d, 2H), 7.57 (m, 2H), 7.64 (m, 3H), 7.91 ( (d, 1H), 8.00 (d, 1H), 8.08 (m, 2H), 8.12

[준비예 4] IC-4의 합성[Preparation Example 4] Synthesis of IC-4

<단계 1> 6-(2-nitrophenyl)-1H-benzo[f]indole의 합성<Step 1> Synthesis of 6- (2-nitrophenyl) -1H-benzo [f] indole

Figure 112012102547714-pat00080
Figure 112012102547714-pat00080

9-phenyl-9H-carbazol-2-amine 대신 6-(2-nitrophenyl)naphthalen-2-amine을 사용하는 것을 제외하고는, 상기 준비예 2의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1H-benzo[f]indole를 얻었다.The procedure of Step 3 of Preparation Example 2 was repeated except that 6- (2-nitrophenyl) naphthalen-2-amine was used in place of 9-phenyl-9H-carbazol- 2-nitrophenyl) -1H-benzo [f] indole.

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.40 (s, 1H), 7.55 (s, 1H), 7.58 (s, 1H), 7.67 (t, 1H), 7.73 (d, 1H), 7.91 (m, 2H), 8.02 (d, 2H), 10.13 (s, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.40 (s, 1H), 7.55 (s, 1H), 7.58 (s, 1H), 7.67 (t, 1H), 7.73 ( (d, IH), 7.91 (m, 2H), 8.02 (d, 2H), 10.13

<단계 2> 6-(2-&Lt; Step 2 > 6- (2- nitrophenylnitrophenyl )-1-)-One- phenylphenyl -1H--1H- benzobenzo [f]indole의 합성Synthesis of [f] indole

Figure 112012102547714-pat00081
Figure 112012102547714-pat00081

6-(2-nitrophenyl)-1H-benzo[g]indole 대신 6-(2-nitrophenyl)-1H-benzo[f]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1-phenyl-1H-benzo[f]indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -1H-benzo [f] indole was used instead of 6- (2-nitrophenyl) -1H- (2-nitrophenyl) -1-phenyl-1H-benzo [f] indole was obtained.

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.42 (m, 2H), 7.50 (d, 2H), 7.55 (s, 1H), 7.58 (m, 3H), 7.67 (t, 1H), 7.73 (d, 1H), 7.91 (m, 2H), 8.02 (d, 2H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.42 (m, 2H), 7.50 (d, 2H), 7.55 (s, 1H), 7.58 (m, 3H), 7.67 ( (d, IH), 7.73 (d, IH), 7.91 (m, 2H), 8.02

<단계 3> <Step 3> ICIC -4의 합성Synthesis of -4

Figure 112012102547714-pat00082
Figure 112012102547714-pat00082

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 6-(2-nitrophenyl)-1-phenyl-1H-benzo[f]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-4를 얻었다.1H-benzo [f] indole was used instead of 6- (2-nitrophenyl) -1-phenyl-1H-benzo [ 1 < Step 4 > to obtain IC-4.

1H-NMR: δ 6.46 (d, 1H), 7.28 (d, 1H), 7.41 (m, 2H), 7.49 (d, 2H), 7.54 (m, 2H), 7.59 (m, 2H), 7.66 (t, 1H), 7.92 (m, 2H), 8.04 (d, 2H), 10.73 (s, 1H)
1 H-NMR: δ 6.46 ( d, 1H), 7.28 (d, 1H), 7.41 (m, 2H), 7.49 (d, 2H), 7.54 (m, 2H), 7.59 (m, 2H), 7.66 ( t, 1 H), 7.92 (m, 2 H), 8.04 (d, 2H), 10.73

[준비예 5] IC-5의 합성[Preparation Example 5] Synthesis of IC-5

Figure 112012102547714-pat00083
Figure 112012102547714-pat00083

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 6-(2-nitrophenyl)-1-phenyl-1H-benzo[f]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-5를 얻었다.1H-benzo [f] indole was used instead of 6- (2-nitrophenyl) -1-phenyl-1H-benzo [ IC-5 was obtained by performing the same procedure as in < Step 4 >

1H-NMR: δ 6.44 (d, 1H), 7.26 (d, 1H), 7.41 (m, 2H), 7.50 (d, 2H), 7.54 (s, 1H), 7.58 (m, 2H), 7.68 (t, 1H), 7.91 (m, 2H), 8.01 (d, 2H), 8.11 (d, 1H), 10.71 (s, 1H)
1 H-NMR: δ 6.44 ( d, 1H), 7.26 (d, 1H), 7.41 (m, 2H), 7.50 (d, 2H), 7.54 (s, 1H), 7.58 (m, 2H), 7.68 ( 1H), 7.91 (m, 2H), 8.01 (d, 2H), 8.11

[준비예 6] IC-6의 합성[Preparation Example 6] Synthesis of IC-6

<단계 1> 2-bromo-7-(2-nitrophenyl)naphthalene의 합성<Step 1> Synthesis of 2-bromo-7- (2-nitrophenyl) naphthalene

Figure 112012102547714-pat00084
Figure 112012102547714-pat00084

2,7-dibromonaphthalene (30 g, 104.91 mmol), 2-nitrophenylboronic acid (21.02 g, 125.89 mmol), Pd(PPh3)4(6.06 g, 5 mol%), K2CO3 (43.50 g, 314.73 mmol) 및 THF/H2O(500 ml/200 ml)를 사용하여, 상기 준비예 1 <단계 2>와 동일한 방법으로 목적 화합물인 2-bromo-6-(2-nitrophenyl)naphthalene (21.34 g, 수율 62 %)를 획득하였다.2,7-dibromonaphthalene (30 g, 104.91 mmol), 2-nitrophenylboronic acid (21.02 g, 125.89 mmol), Pd (PPh 3) 4 (6.06 g, 5 mol%), K 2 CO 3 (43.50 g, 314.73 mmol ) and THF / H 2 O (500 ml / 200 ml) to the preparation example 1 <step 2> the same manner as the desired compound of 2-bromo-6- (2- nitrophenyl) naphthalene (21.34 g, and the yield using 62%).

1H-NMR: δ 7.46 (d, 1H), 7.59 (s, 1H), 7.67 (t, 1H), 7.78 (d, 1H), 7.84 (d, 1H), 7.90 (m, 2H), 8.00 (d, 1H), 8.05 (d, 1H), 8.21 (s, 1H)
1 H-NMR: δ 7.46 ( d, 1H), 7.59 (s, 1H), 7.67 (t, 1H), 7.78 (d, 1H), 7.84 (d, 1H), 7.90 (m, 2H), 8.00 ( d, 1 H), 8.05 (d, 1 H), 8.21 (s, 1 H)

<단계 2> 7-(2-nitrophenyl)naphthalen-2-amine의 합성<Step 2> Synthesis of 7- (2-nitrophenyl) naphthalen-2-amine

Figure 112012102547714-pat00085
Figure 112012102547714-pat00085

2-bromo-6-(2-nitrophenyl)naphthalene 대신 2-bromo-7-(2-nitrophenyl) naphthalene을 사용하는 것을 제외하고는, 상기 준비예 2의 <단계 2>와 동일한 과정을 수행하여 7-(2-nitrophenyl)naphthalen-2-amine를 얻었다.The procedure of Step 2 of Preparation Example 2 was repeated except that 2-bromo-7- (2-nitrophenyl) naphthalene was used instead of 2-bromo-6- (2-nitrophenyl) (2-nitrophenyl) naphthalen-2-amine.

1H-NMR: δ 4.63 (s, 2H), 7.49 (d, 1H), 7.58 (s, 1H), 7.66 (t, 1H), 7.75 (m, 2H), 7.85 (d, 1H), 7.91 (m, 2H), 8.02 (d, 1H), 8.08 (d, 1H)
1 H-NMR: δ 4.63 ( s, 2H), 7.49 (d, 1H), 7.58 (s, 1H), 7.66 (t, 1H), 7.75 (m, 2H), 7.85 (d, 1H), 7.91 ( m, 2 H), 8.02 (d, 1 H), 8.08 (d, 1 H)

<단계 3> 8-(2-nitrophenyl)-3H-benzo[e]indole의 합성<Step 3> Synthesis of 8- (2-nitrophenyl) -3H-benzo [e] indole

Figure 112012102547714-pat00086
Figure 112012102547714-pat00086

9-phenyl-9H-carbazol-2-amine 대신 7-(2-nitrophenyl)naphthalen-2-amine을 사용하는 것을 제외하고는, 상기 준비예 2의 <단계 3>과 동일한 과정을 수행하여 8-(2-nitrophenyl)-3H-benzo[e]indole를 얻었다.The procedure of Step 3 of Preparation Example 2 was repeated except that 7- (2-nitrophenyl) naphthalen-2-amine was used in place of 9-phenyl-9H-carbazol- 2-nitrophenyl) -3H-benzo [e] indole.

1H-NMR: δ 6.44 (d, 1H), 7.27 (d, 1H), 7.58 (s, 1H), 7.66 (m, 2H), 7.77 (d, 1H), 7.85 (d, 1H), 7.91 (m, 2H), 8.02 (d, 1H), 8.08 (d, 1H), 10.11 (s, 1H)
1 H-NMR: δ 6.44 ( d, 1H), 7.27 (d, 1H), 7.58 (s, 1H), 7.66 (m, 2H), 7.77 (d, 1H), 7.85 (d, 1H), 7.91 ( (d, IH), 8.08 (d, IH), 10.11 (s, IH)

<단계 4> 8-(2-nitrophenyl)-3-phenyl-3H-benzo[e]indole의 합성<Step 4> Synthesis of 8- (2-nitrophenyl) -3-phenyl-3H-benzo [e] indole

Figure 112012102547714-pat00087
Figure 112012102547714-pat00087

6-(2-nitrophenyl)-1H-benzo[g]indole 대신 8-(2-nitrophenyl)-3H-benzo[e]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 8-(2-nitrophenyl)-3-phenyl-3H-benzo[e]indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 8- (2-nitrophenyl) -3H-benzo [e] indole was used instead of 6- (2-nitrophenyl) (2-nitrophenyl) -3-phenyl-3H-benzo [e] indole was obtained.

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.45 (m, 1H), 7.51 (d, 2H), 7.59 (m, 3H), 7.67 (m, 2H), 7.78 (d, 1H), 7.86 (d, 1H), 7.92 (m, 2H), 8.04 (d, 1H), 8.10 (d, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.45 (m, 1H), 7.51 (d, 2H), 7.59 (m, 3H), 7.67 (m, 2H), 7.78 ( (d, IH), 7.86 (d, IH), 7.92 (m, 2H), 8.04

<단계 5> IC-6의 합성<Step 5> Synthesis of IC-6

Figure 112012102547714-pat00088
Figure 112012102547714-pat00088

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 8-(2-nitrophenyl)-3-phenyl-3H-benzo[e]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-6를 얻었다.Except that 8- (2-nitrophenyl) -3-phenyl-3H-benzo [e] indole was used in place of 6- (2-nitrophenyl) -1-phenyl- IC-6 was obtained by performing the same procedure as in < Step 4 >

1H-NMR: δ 6.46 (d, 1H), 7.26 (d, 1H), 7.44 (m, 1H), 7.52 (d, 2H), 7.57 (t, 2H), 7.66 (m, 2H), 7.85 (d, 1H), 7.91 (m, 2H), 8.02 (d, 1H), 8.09 (d, 1H), 8.12 (d, 1H), 10.11 (s, 1H)
1 H-NMR: δ 6.46 ( d, 1H), 7.26 (d, 1H), 7.44 (m, 1H), 7.52 (d, 2H), 7.57 (t, 2H), 7.66 (m, 2H), 7.85 ( (d, IH), 7.91 (m, 2H), 8.02 (d, IH), 8.09

[준비예 7] IC-7의 합성[Preparation Example 7] Synthesis of IC-7

Figure 112012102547714-pat00089
Figure 112012102547714-pat00089

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 8-(2-nitrophenyl)-3-phenyl-3H-benzo[e]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-7를 얻었다.Except that 8- (2-nitrophenyl) -3-phenyl-3H-benzo [e] indole was used in place of 6- (2-nitrophenyl) -1-phenyl- 1 < Step 4 >.

1H-NMR: δ 6.46 (d, 1H), 7.26 (d, 1H), 7.43 (m, 2H), 7.51 (d, 1H), 7.56 (s, 1H), 7.60 (m, 2H), 7.69 (m, 2H), 7.85 (d, 1H), 7.91 (m, 2H), 8.03 (d, 1H), 8.11 (d, 1H), 10.12 (s, 1H)
1 H-NMR: δ 6.46 ( d, 1H), 7.26 (d, 1H), 7.43 (m, 2H), 7.51 (d, 1H), 7.56 (s, 1H), 7.60 (m, 2H), 7.69 ( (m, 2H), 7.85 (d, 1H), 7.91 (m, 2H), 8.03

[준비예 8] IC-8의 합성[Preparation Example 8] Synthesis of IC-8

<단계 1> 7-(2-nitrophenyl)-1H-benzo[f]indole의 합성<Step 1> Synthesis of 7- (2-nitrophenyl) -1H-benzo [f] indole

Figure 112012102547714-pat00090
Figure 112012102547714-pat00090

9-phenyl-9H-carbazol-2-amine 대신 7-(2-nitrophenyl)naphthalen-2-amine을 사용하는 것을 제외하고는, 상기 준비예 2의 <단계 3>과 동일한 과정을 수행하여 7-(2-nitrophenyl)-1H-benzo[f]indole를 얻었다.The procedure of Step 3 of Preparation Example 2 was repeated except that 7- (2-nitrophenyl) naphthalen-2-amine was used instead of 9-phenyl-9H-carbazol- 2-nitrophenyl) -1H-benzo [f] indole.

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.40 (s, 1H), 7.55 (s, 1H), 7.58 (s, 1H), 7.67 (t, 1H), 7.73 (d, 1H), 7.91 (m, 2H), 8.03 (m, 2H), 10.11 (s, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.40 (s, 1H), 7.55 (s, 1H), 7.58 (s, 1H), 7.67 (t, 1H), 7.73 ( (d, IH), 7.91 (m, 2H), 8.03 (m, 2H), 10.11

<단계 2> 7-(2-nitrophenyl)-1-phenyl-1H-benzo[f]indole의 합성<Step 2> Synthesis of 7- (2-nitrophenyl) -1-phenyl-1H-benzo [f] indole

Figure 112012102547714-pat00091
Figure 112012102547714-pat00091

6-(2-nitrophenyl)-1H-benzo[g]indole 대신 7-(2-nitrophenyl)-1H-benzo[f]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 7-(2-nitrophenyl)-1-phenyl-1H-benzo[f]indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 7- (2-nitrophenyl) -1H-benzo [f] indole was used instead of 6- (2-nitrophenyl) -1H- To obtain 7- (2-nitrophenyl) -1-phenyl-1H-benzo [f] indole.

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.42 (m, 2H), 7.50 (d, 2H), 7.55 (s, 1H), 7.58 (m, 3H), 7.67 (t, 1H), 7.73 (d, 1H), 7.91 (m, 2H), 8.03 (m, 2H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.42 (m, 2H), 7.50 (d, 2H), 7.55 (s, 1H), 7.58 (m, 3H), 7.67 ( t, 1 H), 7.73 (d, 1 H), 7.91 (m, 2 H), 8.03 (m,

<단계 3> IC-8의 합성<Step 3> Synthesis of IC-8

Figure 112012102547714-pat00092
Figure 112012102547714-pat00092

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 7-(2-nitrophenyl)-1-phenyl-1H-benzo[f]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-8를 얻었다.Except that 7 (2-nitrophenyl) -1-phenyl-1H-benzo [f] indole was used instead of 6- (2-nitrophenyl) 1 < Step 4 >.

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.42 (m, 2H), 7.50 (d, 2H), 7.55 (s, 1H), 7.58 (m, 2H), 7.67 (t, 1H), 7.91 (m, 2H), 8.03 (m, 2H), 8.11 (d, 1H), 11.72 (s, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.42 (m, 2H), 7.50 (d, 2H), 7.55 (s, 1H), 7.58 (m, 2H), 7.67 ( 1H), 7.91 (m, 2H), 8.03 (m, 2H), 8.11

[준비예 9] IC-9의 합성[Preparation Example 9] Synthesis of IC-9

Figure 112012102547714-pat00093
Figure 112012102547714-pat00093

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 7-(2-nitrophenyl)-1-phenyl-1H-benzo[f]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-9를 얻었다.Except that 7 (2-nitrophenyl) -1-phenyl-1H-benzo [f] indole was used instead of 6- (2-nitrophenyl) 1 < Step 4 > to obtain IC-9.

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.42 (m, 2H), 7.50 (d, 2H), 7.55 (s, 1H), 7.58 (m, 2H), 7.67 (t, 1H), 7.91 (m, 2H), 8.03 (m, 2H), 8.09 (s, 1H), 11.71 (s, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.42 (m, 2H), 7.50 (d, 2H), 7.55 (s, 1H), 7.58 (m, 2H), 7.67 ( 1H), 7.91 (m, 2H), 8.03 (m, 2H), 8.09

[준비예 10] IC-10의 합성[Preparation Example 10] Synthesis of IC-10

<단계 1> 1-bromo-8-(2-nitrophenyl)naphthalene의 합성<Step 1> Synthesis of 1-bromo-8- (2-nitrophenyl) naphthalene

Figure 112012102547714-pat00094
Figure 112012102547714-pat00094

1,8-dibromonaphthalene (30 g, 104.91 mmol), 2-nitrophenylboronic acid (21.02 g, 125.89 mmol), Pd(PPh3)4 (6.06 g, 5 mol%), K2CO3 (43.50 g, 314.73 mmol) 및 THF/H2O(500 ml/200 ml)를 사용하여, 상기 준비예 1의 <단계 2>와 동일한 방법으로 목적 화합물인 1-bromo-8-(2-nitrophenyl)naphthalene (21.00 g, 수율 61 %)를 획득하였다.1,8-dibromonaphthalene (30 g, 104.91 mmol), 2-nitrophenylboronic acid (21.02 g, 125.89 mmol), Pd (PPh 3) 4 (6.06 g, 5 mol%), K 2 CO 3 (43.50 g, 314.73 mmol ) and THF / H 2 O (500 ml / 200 ml), the preparation of example 1 <step 2> the same manner as the desired compound of 1-bromo-8- (2- nitrophenyl) naphthalene (21.00 g , and using, Yield: 61%).

1H-NMR: δ 7.46 (t, 1H), 7.67 (t, 1H), 7.72 (t, 1H), 7.90 (t, 1H), 7.98 (d, 2H), 8.05 (d, 1H), 8.09 (d, 1H), 8.12 (d, 2H)
1 H-NMR: δ 7.46 ( t, 1H), 7.67 (t, 1H), 7.72 (t, 1H), 7.90 (t, 1H), 7.98 (d, 2H), 8.05 (d, 1H), 8.09 ( d, 1 H), 8.12 (d, 2H)

<단계 2> 8-(2-nitrophenyl)naphthalen-1-amine의 합성<Step 2> Synthesis of 8- (2-nitrophenyl) naphthalen-1-amine

Figure 112012102547714-pat00095
Figure 112012102547714-pat00095

2-bromo-6-(2-nitrophenyl)naphthalene 대신 1-bromo-8-(2-nitrophenyl) naphthalene을 사용하는 것을 제외하고는, 상기 준비예 2의 <단계 2>와 동일한 과정을 수행하여 8-(2-nitrophenyl)naphthalen-1-amine를 얻었다.Step 2 of Preparation Example 2 was carried out except that 1-bromo-8- (2-nitrophenyl) naphthalene was used in place of 2-bromo-6- (2-nitrophenyl) (2-nitrophenyl) naphthalen-1-amine.

1H-NMR: δ 5.79 (s, 2H), 7.45 (t, 1H), 7.66 (t, 1H), 7.73 (t, 1H), 7.81 (t, 1H), 7.89 (d, 2H), 7.94 (d, 1H), 8.00 (d, 1H), 8.09 (d, 2H)
1 H-NMR: δ 5.79 ( s, 2H), 7.45 (t, 1H), 7.66 (t, 1H), 7.73 (t, 1H), 7.81 (t, 1H), 7.89 (d, 2H), 7.94 ( d, 1 H), 8.00 (d, 1 H), 8.09 (d, 2 H)

<단계 3> 9-(2-nitrophenyl)-1H-benzo[g]indole의 합성<Step 3> Synthesis of 9- (2-nitrophenyl) -1H-benzo [g] indole

Figure 112012102547714-pat00096
Figure 112012102547714-pat00096

9-phenyl-9H-carbazol-2-amine 대신 8-(2-nitrophenyl)naphthalen-1-amine을 사용하는 것을 제외하고는, 상기 준비예 2의 <단계 3>과 동일한 과정을 수행하여 9-(2-nitrophenyl)-1H-benzo[g]indole를 얻었다.The procedure of Step 3 of Preparation Example 2 was repeated except that 8- (2-nitrophenyl) naphthalen-1-amine was used instead of 9-phenyl-9H-carbazol- 2-nitrophenyl) -1H-benzo [g] indole.

1H-NMR: δ 6.44 (d, 1H), 7.26 (d, 1H), 7.45 (t, 1H), 7.66 (t, 1H), 7.73 (d, 1H), 7.81 (d, 1H), 7.89 (d, 2H), 7.94 (d, 1H), 8.00 (d, 1H), 8.09 (d, 1H), 10.15 (s, 1H)
1 H-NMR: δ 6.44 ( d, 1H), 7.26 (d, 1H), 7.45 (t, 1H), 7.66 (t, 1H), 7.73 (d, 1H), 7.81 (d, 1H), 7.89 ( (d, IH), 8.09 (d, IH), 10.15 (s, IH)

<단계 4> 9-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole의 합성<Step 4> Synthesis of 9- (2-nitrophenyl) -1-phenyl-1H-benzo [g] indole

Figure 112012102547714-pat00097
Figure 112012102547714-pat00097

6-(2-nitrophenyl)-1H-benzo[g]indole 대신 9-(2-nitrophenyl)-1H-benzo[g]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 9-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 9- (2-nitrophenyl) -1H-benzo [g] indole was used instead of 6- (2-nitrophenyl) (2-nitrophenyl) -1-phenyl-1H-benzo [g] indole was obtained.

1H-NMR: δ 6.44 (d, 1H), 7.26 (d, 1H), 7.45 (m, 2H), 7.50 (d, 2H), 7.57 (t, 2H), 7.66 (t, 1H), 7.73 (d, 1H), 7.81 (d, 1H), 7.89 (d, 2H), 7.94 (d, 1H), 8.00 (d, 1H), 8.09 (d, 1H)
1 H-NMR: δ 6.44 ( d, 1H), 7.26 (d, 1H), 7.45 (m, 2H), 7.50 (d, 2H), 7.57 (t, 2H), 7.66 (t, 1H), 7.73 ( (d, IH), 7.81 (d, IH), 7.89 (d,

<단계 5> IC-10의 합성<Step 5> Synthesis of IC-10

Figure 112012102547714-pat00098
Figure 112012102547714-pat00098

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 9-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-10를 얻었다.Except that 9- (2-nitrophenyl) -1-phenyl-1H-benzo [g] indole was used in place of 6- (2-nitrophenyl) 1 < Step 4 > to obtain IC-10.

1H-NMR: δ 6.43 (d, 1H), 7.25 (d, 1H), 7.44 (m, 2H), 7.51 (d, 2H), 7.56 (d, 1H), 7.65 (d, 1H), 7.72 (d, 1H), 7.80 (d, 1H), 7.90 (d, 2H), 7.95 (d, 1H), 8.02 (d, 1H), 8.11 (d, 1H), 10.71 (s, 1H)
1 H-NMR: δ 6.43 ( d, 1H), 7.25 (d, 1H), 7.44 (m, 2H), 7.51 (d, 2H), 7.56 (d, 1H), 7.65 (d, 1H), 7.72 ( (d, 1H), 7.80 (d, 1H), 7.90 (d, 2H), 7.95

[준비예 11] IC-11의 합성[Preparation Example 11] Synthesis of IC-11

<단계 1> 6-(2-nitronaphthalen-1-yl)-1H-benzo[g]indole의 합성<Step 1> Synthesis of 6- (2-nitronaphthalen-1-yl) -1H-benzo [g] indole

Figure 112012102547714-pat00099
Figure 112012102547714-pat00099

6-bromo-1H-benzo[g]indole (30 g, 121.90 mmol), 2-nitronaphthalen-1-ylboronic acid (31.74 g, 146.28 mmol), Pd(PPh3)4(7.04 g, 5 mol%), K2CO3 (50.54 g, 365.70 mmol) 및 THF/H2O(500 ml/200 ml)를 사용하여, 상기 준비예 1의 <단계 2>와 동일한 방법으로 목적 화합물인 6-(2-nitronaphthalen-1-yl)-1H-benzo[g]indole (31.34 g, 수율 76 %)를 획득하였다.6-bromo-1H-benzo [ g] indole (30 g, 121.90 mmol), 2-nitronaphthalen-1-ylboronic acid (31.74 g, 146.28 mmol), Pd (PPh 3) 4 (7.04 g, 5 mol%), (2-nitronaphthalen-1-ylamine) was obtained in the same manner as in <Step 2> of Preparation Example 1, using K 2 CO 3 (50.54 g, 365.70 mmol) and THF / H 2 O -1-yl) -1H-benzo [g] indole (31.34 g, yield 76%).

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.59 (m, 2H), 7.80 (m, 2H), 8.04 (d, 1H), 8.12 (d, 1H), 8.24 (d, 2H), 8.34 (d, 1H), 8.43 (d, 1H), 8.81 (d, 1H), 10.13 (s, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.59 (m, 2H), 7.80 (m, 2H), 8.04 (d, 1H), 8.12 (d, 1H), 8.24 ( (d, IH), 8.34 (d, IH), 8.43 (d,

<단계 2> 6-(2-nitronaphthalen-1-yl)-1-phenyl-1H-benzo[g]indole의 합성<Step 2> Synthesis of 6- (2-nitronaphthalen-1-yl) -1-phenyl-1H-benzo [g]

Figure 112012102547714-pat00100
Figure 112012102547714-pat00100

6-(2-nitrophenyl)-1H-benzo[g]indole 대신 6-(2-nitronaphthalen-1-yl)-1H-benzo[g]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitronaphthalen-1-yl)-1-phenyl-1H-benzo[g] indole을 얻었다.Except that 6- (2-nitronaphthalen-1-yl) -1H-benzo [g] indole was used in place of 6- (2-nitrophenyl) -1H- 3] was carried out to obtain 6- (2-nitronaphthalen-1-yl) -1-phenyl-1H-benzo [g] indole.

1H-NMR: δ 6.44 (d, 1H), 7.26 (d, 1H), 7.45 (m, 1H), 7.50 (d, 2H), 7.58 (m, 4H), 7.81 (m, 2H), 8.02 (d, 1H), 8.11 (d, 1H), 8.23 (d, 2H), 8.32 (d, 1H), 8.41 (d, 1H), 8.79 (d, 1H)
1 H-NMR: δ 6.44 ( d, 1H), 7.26 (d, 1H), 7.45 (m, 1H), 7.50 (d, 2H), 7.58 (m, 4H), 7.81 (m, 2H), 8.02 ( (d, IH), 8.11 (d, IH), 8.23 (d, 2H), 8.32

<단계 3> IC-11의 합성<Step 3> Synthesis of IC-11

Figure 112012102547714-pat00101
Figure 112012102547714-pat00101

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 6-(2-nitronaphthalen-1-yl)-1-phenyl-1H-benzo[g]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-11를 얻었다.Except that 6- (2-nitronaphthalen-1-yl) -1-phenyl-1H-benzo [g] indole was used instead of 6- (2-nitrophenyl) -1-phenyl- , &Lt; Step 4 > of Preparation Example 1 was performed to obtain IC-11.

1H-NMR: δ 6.46 (d, 1H), 7.27 (d, 1H), 7.44 (m, 1H), 7.51 (d, 2H), 7.61 (m, 4H), 7.80 (m, 2H), 8.01 (d, 1H), 8.10 (d, 1H), 8.22 (d, 2H), 8.31 (d, 1H), 8.78 (d, 1H), 11.72 (s, 1H)
1 H-NMR: δ 6.46 ( d, 1H), 7.27 (d, 1H), 7.44 (m, 1H), 7.51 (d, 2H), 7.61 (m, 4H), 7.80 (m, 2H), 8.01 ( (d, IH), 8.10 (d, IH), 8.22 (d, 2H), 8.31

[준비예 12] IC-12의 합성[Preparation Example 12] Synthesis of IC-12

<단계 1> 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[g] indole의 합성Synthesis of 6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-benzo [g] indole

Figure 112012102547714-pat00102
Figure 112012102547714-pat00102

질소 기류 하에서 6-bromo-1H-benzo[g]indole (30 g, 121.90 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (37.15 g, 146.28 mmol), Pd(dppf)Cl2 (4.98 g, 5 mol%), KOAc (35.89 g, 365.70 mmol) 및 1,4-dioxane (800 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane : EA = 10:1 (v/v))로 정제하여 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[g]indole (26.45 g, 수율 74%)을 얻었다. Indole (30 g, 121.90 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi Dioxane (800 ml), Pd (dppf) Cl 2 (4.98 g, 5 mol%), KOAc (35.89 g, 365.70 mmol), and 1,3-dioxaborolane (37.15 g, 146.28 mmol) Were mixed and stirred at 130 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 6- (4,4,5,5-tetramethyl -1,3,2-dioxaborolan-2-yl) -1H-benzo [g] indole (26.45 g, yield 74%).

1H-NMR: δ 1.24 (s, 12H), 6.45 (d, 1H), 7.28 (d, 2H), 7.56 (d, 2H), 8.08 (d, 1H), 8.12 (d, 1H), 10.12 (s, 1H)
1 H-NMR: δ 1.24 ( s, 12H), 6.45 (d, 1H), 7.28 (d, 2H), 7.56 (d, 2H), 8.08 (d, 1H), 8.12 (d, 1H), 10.12 ( s, 1 H)

<단계 2> 6-(5-bromo-2-nitrophenyl)-1H-benzo[g]indole의 합성<Step 2> Synthesis of 6- (5-bromo-2-nitrophenyl) -1H-benzo [g] indole

Figure 112012102547714-pat00103
Figure 112012102547714-pat00103

6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[g]indole (25 g, 85.27 mmol), 2,4-dibromo-1-nitrobenzene (28.74 g, 102.33 mmol), Pd(PPh3)4(4.93 g, 5 mol%), K2CO3 (35.36 g, 255.82 mmol) 및 THF/H2O(500 ml/200 ml)를 사용하여, 상기 준비예 1의 <단계 2>와 동일한 방법으로 목적 화합물인 6-(5-bromo-2-nitrophenyl)-1H-benzo[g]indole (13.46 g, 수율 43 %)를 획득하였다.2-yl) -1H-benzo [g] indole (25 g, 85.27 mmol), 2,4-dibromo-1-nitrobenzene using (28.74 g, 102.33 mmol), Pd (PPh 3) 4 (4.93 g, 5 mol%), K 2 CO 3 (35.36 g, 255.82 mmol) and THF / H 2 O (500 ml / 200 ml) , 5-bromo-2-nitrophenyl) -1 H-benzo [g] indole (13.46 g, yield 43%) was obtained in the same manner as in <Step 2> of Preparation Example 1.

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 8.12 (d, 1H), 7.57 (d, 1H), 7.72 (s, 1H), 7.98 (d, 1H), 8.21 (d, 1H), 8.42 (d, 1H), 7.61 (t, 1H), 8.04 (d, 1H), 10.13 (s, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 8.12 (d, 1H), 7.57 (d, 1H), 7.72 (s, 1H), 7.98 (d, 1H), 8.21 ( 1H), 8.42 (d, 1H), 7.61 (t, 1H), 8.04

<단계 3> 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-benzo[g]indole의 합성Step 3 Synthesis of 6- (5-bromo-2-nitrophenyl) -1-phenyl-1H-benzo [g] indole

Figure 112012102547714-pat00104
Figure 112012102547714-pat00104

6-(2-nitrophenyl)-1H-benzo[g]indole 대신 6-(5-bromo-2-nitrophenyl)-1H-benzo[g]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-benzo[g]indole을 얻었다.Except that 6- (5-bromo-2-nitrophenyl) -1H-benzo [g] indole was used in place of 6- (2-nitrophenyl) -1H- 3] was performed to obtain 6- (5-bromo-2-nitrophenyl) -1-phenyl-1H-benzo [g] indole.

1H-NMR: δ 6.45 (d, 1H), 7.27 (d, 1H), 7.45 (m, 1H), 7.50 (d, 2H), 7.61 (t, 2H), 8.12 (d, 1H), 7.57 (d, 1H), 7.72 (s, 1H), 7.98 (d, 1H), 8.21 (d, 1H), 8.42 (d, 1H), 7.61 (t, 1H), 8.04 (d, 1H)
1 H-NMR: δ 6.45 ( d, 1H), 7.27 (d, 1H), 7.45 (m, 1H), 7.50 (d, 2H), 7.61 (t, 2H), 8.12 (d, 1H), 7.57 ( (d, IH), 7.72 (s, IH), 7.98 (d, IH), 8.21

<단계 4> 9-bromo-3-phenyl-3,6-dihydroindolo[7,6-c]carbazole의 합성<Step 4> Synthesis of 9-bromo-3-phenyl-3,6-dihydroindolo [7,6-c] carbazole

Figure 112012102547714-pat00105
Figure 112012102547714-pat00105

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-benzo[g]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 9-bromo-3-phenyl-3,6-dihydroindolo[7,6-c]carbazole를 얻었다.Except that 6- (5-bromo-2-nitrophenyl) -1-phenyl-1H-benzo [g] indole was used instead of 6- (2-nitrophenyl) Bromo-3-phenyl-3,6-dihydroindolo [7,6-c] carbazole was obtained in the same manner as in <Step 4> of Preparation Example 1 above.

1H-NMR: δ 6.51 (d, 1H), 7.43 (m, 2H), 7.51 (d, 3H), 7.59 (m, 3H), 7.64 (d, 2H), 7.88 (d, 1H), 8.05 (s, 1H), 8.43 (d, 1H), 11.70 (s, 1H)
1 H-NMR: δ 6.51 ( d, 1H), 7.43 (m, 2H), 7.51 (d, 3H), 7.59 (m, 3H), 7.64 (d, 2H), 7.88 (d, 1H), 8.05 ( s, 1 H), 8.43 (d, 1 H), 11.70 (s, 1 H)

<단계 5> IC-12의 합성<Step 5> Synthesis of IC-12

Figure 112012102547714-pat00106
Figure 112012102547714-pat00106

6-(2-nitrophenyl)-1H-benzo[g]indole 대신 9-bromo-3-phenyl-3,6-dihydroindolo[7,6-c]carbazole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 IC-12을 얻었다.Except that 9-bromo-3-phenyl-3,6-dihydroindolo [7,6-c] carbazole was used in place of 6- (2-nitrophenyl) -1H- IC-12 was obtained by performing the same procedure as in < Step 3 >.

1H-NMR: δ 6.50 (d, 1H), 7.41 (m, 3H), 7.50 (m, 5H), 7.57 (m, 5H), 7.65 (d, 2H), 7.89 (d, 1H), 8.06 (s, 1H), 8.41 (d, 1H)
1 H-NMR: δ 6.50 ( d, 1H), 7.41 (m, 3H), 7.50 (m, 5H), 7.57 (m, 5H), 7.65 (d, 2H), 7.89 (d, 1H), 8.06 ( s, 1 H), 8.41 (d, 1 H)

[준비예 13] IC-13의 합성[Preparation Example 13] Synthesis of IC-13

<단계 1> 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-benzo[g]indole의 합성Synthesis of 1- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -6- (2-nitrophenyl) -1H-benzo [g] indole

Figure 112012102547714-pat00107
Figure 112012102547714-pat00107

질소 기류 하에서 6-(2-nitrophenyl)-1H-benzo[g]indole (20 g, 69.37 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (28.61 g, 83.25 mmol), Pd(OAc)2 (0.78 g, 5 mol%), NaO(t-bu) (16.67 g, 173.43 mmol), P(t-bu)3 (1.40 g, 3.47 mmol) 및 Toluene (500 ml)을 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane : EA = 2:1 (v/v))로 정제하여 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-benzo[g]indole (28.10 g, 수율 68 %)을 얻었다. Indole (20 g, 69.37 mmol) and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (28.61 g, , 83.25 mmol), Pd (OAc ) 2 (0.78 g, 5 mol%), NaO (t-bu) (16.67 g, 173.43 mmol), P (t-bu) 3 (1.40 g, 3.47 mmol) and Toluene ( 500 ml) were mixed and stirred at 110 ° C for 12 hours. The reaction was extracted with ethyl acetate and then terminated, and then remove the water with MgSO 4 and purified by column chromatography (Hexane: EA = 2: 1 (v / v)) to give 1- (3- (4,6-diphenyl- 1,3,5-triazin-2-yl) phenyl) -6- (2-nitrophenyl) -1H-benzo [g] indole (28.10 g, yield 68%).

GC-Mass (이론치: 595.20 g/mol, 측정치: 595 g/mol)
GC-Mass (theory: 595.20 g / mol, measured: 595 g / mol)

<단계 2> IC-13의 합성<Step 2> Synthesis of IC-13

Figure 112012102547714-pat00108
Figure 112012102547714-pat00108

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-benzo[g]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-13를 얻었다.(4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -6- (2-pyridyl) IC-13 was obtained in the same manner as in <Step 4> of Preparation Example 1 except that 2-nitrophenyl-1H-benzo [g] indole was used.

GC-Mass (이론치: 563.21 g/mol, 측정치: 563 g/mol)
GC-Mass (calculated: 563.21 g / mol, measured: 563 g / mol)

[준비예 14] IC-14의 합성[Preparation Example 14] Synthesis of IC-14

<단계 1> 1-(4,6-diphenylpyridin-2-yl)-6-(2-nitrophenyl)-1H-benzo[g]indole의 합성<Step 1> Synthesis of 1- (4,6-diphenylpyridin-2-yl) -6- (2-nitrophenyl) -1H-benzo [g] indole

Figure 112012102547714-pat00109
Figure 112012102547714-pat00109

Iodobenzene 대신 2-bromo-4,6-diphenylpyridine을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 1-(4,6-diphenylpyridin-2-yl)-6-(2-nitrophenyl)-1H-benzo[g]indole을 얻었다.(4,6-diphenylpyridin-2-yl) -6- (4-methylphenyl) pyridine was prepared by following the procedure of Step 3 of Preparation Example 1, except that 2-bromo-4,6-diphenylpyridine was used in place of iodobenzene. (2-nitrophenyl) -1H-benzo [g] indole.

GC-Mass (이론치: 517.18 g/mol, 측정치: 517 g/mol)
GC-Mass (calculated: 517.18 g / mol, measured: 517 g / mol)

<단계 2> IC-14의 합성<Step 2> Synthesis of IC-14

Figure 112012102547714-pat00110
Figure 112012102547714-pat00110

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 1-(4,6-diphenylpyridin-2-yl)-6-(2-nitrophenyl)-1H-benzo[g]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-14를 얻었다.(4-diphenylpyridin-2-yl) -6- (2-nitrophenyl) -1H-benzo [g] indole instead of 6- (2-nitrophenyl) IC-14 was obtained by carrying out the same procedure as < Step 4 >

GC-Mass (이론치: 485.19 g/mol, 측정치: 485 g/mol)
GC-Mass (calculated: 485.19 g / mol, measured: 485 g / mol)

[준비예 15] IC-15의 합성[Preparation Example 15] Synthesis of IC-15

<단계 1> 6-(2-nitrophenyl)-1-o-tolyl-1H-benzo[g]indole의 합성<Step 1> Synthesis of 6- (2-nitrophenyl) -1-o-tolyl-1H-benzo [g] indole

Figure 112012102547714-pat00111
Figure 112012102547714-pat00111

Iodobenzene 대신 1-iodo-2-methylbenzene을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1-o-tolyl-1H-benzo[g]indole을 얻었다.2-nitrophenyl) -1-o-tolyl-1H-benzo [b] thiophene was carried out by following the procedure of Step 3 of Preparation Example 1, except that 1-iodo-2- g] indole.

1H-NMR: δ 1.92 (s, 3H), 6.52 (d, 1H), 7.22 (d, 1H), 7.33 (t, 1H), 7.39 (t, 1H), 7.48 (d, 1H), 7.60 (m, 2H) 7.67 (t, 1H), 7.89 (m, 2H), 8.00 (d, 1H), 8.05 (d, 2H), 8.12 (d, 2H)
1 H-NMR: δ 1.92 ( s, 3H), 6.52 (d, 1H), 7.22 (d, 1H), 7.33 (t, 1H), 7.39 (t, 1H), 7.48 (d, 1H), 7.60 ( 2H), 8.12 (d, 2H), 7.87 (m, 2H)

<단계 2> IC-15의 합성<Step 2> Synthesis of IC-15

Figure 112012102547714-pat00112
Figure 112012102547714-pat00112

6-(2-nitrophenyl)-1-phenyl-1H-benzo[g]indole 대신 6-(2-nitrophenyl)-1-o-tolyl-1H-benzo[g]indole을 사용하는 것을 제외하고는, 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-15를 얻었다.Except that 6- (2-nitrophenyl) -1-o-tolyl-1H-benzo [g] indole was used instead of 6- (2-nitrophenyl) IC-15 was obtained by carrying out the same procedure as <Step 4> of Preparation Example 1.

1H-NMR: δ 1.91 (s, 3H), 6.53 (d, 1H), 7.23 (d, 1H), 7.34 (t, 1H), 7.40 (t, 1H), 7.50 (d, 1H), 7.61 (m, 2H) 7.68 (d, 1H), 7.88 (m, 2H), 8.01 (d, 1H), 8.07 (d, 2H), 8.14 (d, 1H), 10.67 (s, 1H)
1 H-NMR: δ 1.91 ( s, 3H), 6.53 (d, 1H), 7.23 (d, 1H), 7.34 (t, 1H), 7.40 (t, 1H), 7.50 (d, 1H), 7.61 ( 2H), 8.14 (d, 1H), 10.67 (s, 1H), 8.08 (d,

[합성예 1] Inv-1의 합성[Synthesis Example 1] Synthesis of Inv-1

Figure 112012102547714-pat00113
Figure 112012102547714-pat00113

질소 기류 하에서 IC-1 (3 g, 9.03 mmol), 2-bromo-4,6-diphenylpyridine (4.20 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)를 혼합하고 200℃에서 24시간 동안 교반하였다. 반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane : MC = 1:1 (v/v))로 정제하여 목적 화합물인 Inv-1 (2.74 g, 수율 54 %)을 얻었다. 2-bromo-4,6-diphenylpyridine (4.20 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol) mmol), Na 2 SO 4 (1.28 g, 9.03 mmol) and nitrobenzene (100 ml) were mixed and stirred at 200 ° C for 24 hours. After completion of the reaction, the nitrobenzene was removed. The organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent was removed from the organic layer from which water had been removed, and the residue was purified by column chromatography (Hexane: MC = 1: 1 (v / v)) to obtain the target compound Inv-1 (2.74 g, yield 54%).

GC-Mass (이론치: 561.22 g/mol, 측정치: 561 g/mol)
GC-Mass (calculated: 561.22 g / mol, measured: 561 g / mol)

[합성예 2] Inv-2의 합성[Synthesis Example 2] Synthesis of Inv-2

Figure 112012102547714-pat00114
Figure 112012102547714-pat00114

질소 하에서 NaH 0.32 g (13.54 mmol)을 50 ml DMF에 넣어 교반하였다. 여기에 DMF 50 ml에 녹인 IC-1 3g (9.03 mmol)을 천천히 첨가하고 1시간 가량 교반하였다. 이어서 DMF 100ml에 녹인 2-chloro-4,6-diphenyl-1,3,5-triazine 3.62g (13.54 mmol)을 천천히 첨가하고 12시간 동안 교반하였다. 반응 종료 후 혼합물을 실리카 필터링하고 물과 메탄올로 씻은 후 용매를 제거하여 목적 화합물인 Inv-2 (3.87 g, 수율 76 %)을 얻었다.Under nitrogen, 0.32 g (13.54 mmol) of NaH was added to 50 ml of DMF and stirred. 3 g (9.03 mmol) of IC-1 dissolved in 50 ml of DMF was added slowly and stirred for about 1 hour. Then 3.62 g (13.54 mmol) of 2-chloro-4,6-diphenyl-1,3,5-triazine dissolved in 100 ml of DMF was added slowly and stirred for 12 hours. After completion of the reaction, the mixture was filtered through silica, washed with water and methanol, and then the solvent was removed to obtain the objective compound Inv-2 (3.87 g, yield 76%).

GC-Mass (이론치: 563.21 g/mol, 측정치: 563 g/mol)
GC-Mass (calculated: 563.21 g / mol, measured: 563 g / mol)

[합성예 3] Inv-3의 합성[Synthesis Example 3] Synthesis of Inv-3

Figure 112012102547714-pat00115
Figure 112012102547714-pat00115

질소 기류 하에서 IC-1 (3 g, 9.03 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (3.72 g, 10.83 mmol), Pd(OAc)2 (0.10 g, 5 mol%), NaO(t-bu) (2.17 g, 22.56 mmol), P(t-bu)3 (0.18 g, 0.90 mmol) 및 Toluene (100 ml)을 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 2:1 (v/v))로 정제하여 목적 화합물인 Inv-3 (4.04 g, 수율 70 %)을 얻었다. (3 g, 9.03 mmol), 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.72 g, 10.83 mmol), Pd (OAc) 2 g, 5 mol%), NaO (t-bu) (2.17 g, 22.56 mmol), P (t-bu) 3 (0.18 g, 0.90 mmol) and a mixture of Toluene (100 ml) and for 12 hours at 110 ℃ Lt; / RTI &gt; After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 2: 1 (v / v)) to obtain 4.0 g of the objective compound Inv-3 %).

GC-Mass (이론치: 639.24 g/mol, 측정치: 639 g/mol)
GC-Mass (calculated: 639.24 g / mol, measured: 639 g / mol)

[합성예 4] Inv-4의 합성[Synthesis Example 4] Synthesis of Inv-4

Figure 112012102547714-pat00116
Figure 112012102547714-pat00116

IC-1 (3 g, 9.03 mmol), 6-bromo-2,3'-bipyridine (3.18 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-4 (2.28 g, 수율 52 %)를 획득하였다.(3.18 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), IC-1 (3 g, 9.03 mmol), 6-bromo-2,3'-bipyridine , using Na 2 SO 4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml), was obtained in Inv-4 (2.28 g, yield 52%) of the target compound in the same manner as in synthesis example 1.

GC-Mass (이론치: 486.18 g/mol, 측정치: 486 g/mol)
GC-Mass (calculated: 486.18 g / mol, measured: 486 g / mol)

[합성예 5] Inv-5의 합성[Synthesis Example 5] Synthesis of Inv-5

Figure 112012102547714-pat00117
Figure 112012102547714-pat00117

IC-1 (3 g, 9.03 mmol), 3-bromo-9-phenyl-9H-carbazole (4.36 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-5 (3.11 g, 수율 60 %)를 획득하였다.IC-1 (3 g, 9.03 mmol), 3-bromo-9-phenyl-9H-carbazole (4.36 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol ), Na 2 SO 4 (1.28 g, using 9.03 mmol), nitrobenzene (100 ml ), was obtained in Inv-5 (3.11 g, yield 60%) of the target compound in the same manner as in synthesis example 1.

GC-Mass (이론치: 573.22 g/mol, 측정치: 573 g/mol)
GC-Mass (calculated: 573.22 g / mol, measured: 573 g / mol)

[합성예 6] Inv-6의 합성[Synthesis Example 6] Synthesis of Inv-6

Figure 112012102547714-pat00118
Figure 112012102547714-pat00118

IC-1 (3 g, 9.03 mmol), 2-(3'-chlorobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (4.56 g, 10.83 mmol), Pd(OAc)2 (0.10 g, 5 mol%), NaO(t-bu) (2.17 g, 22.56 mmol), P(t-bu)3 (0.18 g, 0.90 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 3과 동일한 방법으로 목적 화합물 Inv-6 (4.39 g, 수율 68 %)을 획득하였다. 3-yl) -4,6-diphenyl-1,3,5-triazine (4.56 g, 10.83 mmol), Pd (OAc) 2 (0.10 g, 5 mol%), NaO (t-bu) (2.17 g, 22.56 mmol), P (t-bu) 3 (0.18 g, 0.90 mmol) and Toluene 3, the objective compound Inv-6 (4.39 g, yield 68%) was obtained.

GC-Mass (이론치: 715.27 g/mol, 측정치: 715 g/mol)
GC-Mass (calculated: 715.27 g / mol, measured: 715 g / mol)

[합성예 7] Inv-7의 합성[Synthesis Example 7] Synthesis of Inv-7

Figure 112012102547714-pat00119
Figure 112012102547714-pat00119

IC-2 (3 g, 9.03 mmol), 4-bromoisoquinoline (2.82 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-7 (1.99 g, 수율 48 %)을 획득하였다.(2.82 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), Na 2 SO 4 (1.28 g, 9.03 mmol) and nitrobenzene (100 ml), the target compound Inv-7 (1.99 g, yield 48%) was obtained in the same manner as in Synthesis Example 1. [

GC-Mass (이론치: 459.17 g/mol, 측정치: 459 g/mol)
GC-Mass (459.17 g / mol, measured: 459 g / mol)

[합성예 8] Inv-8의 합성[Synthesis Example 8] Synthesis of Inv-8

Figure 112012102547714-pat00120
Figure 112012102547714-pat00120

IC-2 (3 g, 9.03 mmol), 2-(4-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (3.72 g, 10.83 mmol), Pd(OAc)2 (0.10 g, 5 mol%), NaO(t-bu) (2.17 g, 22.56 mmol), P(t-bu)3 (0.18 g, 0.90 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 3과 동일한 방법으로 목적 화합물 Inv-8 (3.87 g, 수율 67 %)을 획득하였다. (3.72 g, 10.83 mmol), Pd (OAc) 2 (0.10 g, 5 mmol), IC-2 (3 g, 9.03 mmol), 2- (4- chlorophenyl) -4,6- mol%), using NaO (t-bu) (2.17 g, 22.56 mmol), P (t-bu) 3 (0.18 g, 0.90 mmol) and Toluene (100 ml), in the same manner as in synthesis example 3 The target compound Inv-8 (3.87 g, yield 67%) was obtained.

GC-Mass (이론치: 639.24 g/mol, 측정치: 639 g/mol)
GC-Mass (calculated: 639.24 g / mol, measured: 639 g / mol)

[합성예 9] Inv-9의 합성[Synthesis Example 9] Synthesis of Inv-9

Figure 112012102547714-pat00121
Figure 112012102547714-pat00121

IC-3 (3 g, 9.03 mmol), 2-(4-chlorophenyl)-4,6-diphenylpyrimidine (3.71g, 10.83 mmol), Pd(OAc)2 (0.10 g, 5 mol%), NaO(t-bu) (2.17 g, 22.56 mmol), P(t-bu)3 (0.18 g, 0.90 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 3과 동일한 방법으로 목적 화합물 Inv-9 (3.92 g, 수율 68 %)을 획득하였다. Pd (OAc) 2 (0.10 g, 5 mol%), NaO (t-Butylpyrimidine) (3.71 g, 10.83 mmol), IC- bu) (2.17 g, 22.56 mmol ), P (t-bu) 3 (0.18 g, 0.90 mmol) and Toluene (100 ml), the same method the desired compound Inv-9 (3.92 g in the above synthesis example 3 using , Yield 68%).

GC-Mass (이론치: 638.25 g/mol, 측정치: 638 g/mol)
GC-Mass (calculated: 638.25 g / mol, measured: 638 g / mol)

[합성예 10] Inv-10의 합성[Synthesis Example 10] Synthesis of Inv-10

Figure 112012102547714-pat00122
Figure 112012102547714-pat00122

IC-3 (3 g, 9.03 mmol), 2-(4-bromophenyl)pyridine (3.17 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-10 (1.80 g, 수율 41 %)를 획득하였다.(3.16 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), Na 2 SO 4 using a (1.28 g, 9.03 mmol), nitrobenzene (100 ml), was obtained in Inv-10 (1.80 g, yield 41%) of the desired compound in the same manner as in synthesis example 1.

GC-Mass (이론치: 485.19 g/mol, 측정치: 485 g/mol)
GC-Mass (calculated: 485.19 g / mol, measured: 485 g / mol)

[합성예 11] Inv-11의 합성[Synthesis Example 11] Synthesis of Inv-11

Figure 112012102547714-pat00123
Figure 112012102547714-pat00123

IC-4 (3 g, 9.03 mmol), 4-bromo-N,N-diphenylaniline (4.39 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-11 (2.86 g, 수율 55 %)를 획득하였다.Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), IC-4 (3 g, 9.03 mmol), 4-bromo- N, N diphenylaniline (4.39 g, 13.54 mmol) using Na 2 SO 4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml), was obtained in Inv-11 (2.86 g, yield 55%) of the target compound in the same manner as in synthesis example 1.

GC-Mass (이론치: 575.24 g/mol, 측정치: 575 g/mol)
GC-Mass (calculated: 575.24 g / mol, measured: 575 g / mol)

[합성예 12] Inv-12의 합성[Synthesis Example 12] Synthesis of Inv-12

Figure 112012102547714-pat00124
Figure 112012102547714-pat00124

IC-4 (3 g, 9.03 mmol), 4-(4-bromophenyl)isoquinoline (3.85 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-12 (2.32 g, 수율 48 %)를 획득하였다.(3.85 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), Na Inv-12 (2.32 g, yield 48%) was obtained in the same manner as in Synthesis Example 1, using 2- SO 4 (1.28 g, 9.03 mmol) and nitrobenzene (100 ml).

GC-Mass (이론치: 535.20 g/mol, 측정치: 535 g/mol)
GC-Mass (calculated: 535.20 g / mol, measured: 535 g / mol)

[합성예 13] Inv-13의 합성[Synthesis Example 13] Synthesis of Inv-13

Figure 112012102547714-pat00125
Figure 112012102547714-pat00125

IC-5 (3 g, 9.03 mmol), 3-bromo-9-(4,6-diphenylpyridin-2-yl)-9H-carbazole (6.44 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-4 (2.56 g, 수율 39 %)를 획득하였다.3-bromo-9- (4,6-diphenylpyridin-2-yl) -9H-carbazole (6.44 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), IC- Inv-4 (2.56 g, 0.032 mmol) was obtained in the same manner as in Synthesis Example 1, using K 2 CO 3 (1.25 g, 9.03 mmol), Na 2 SO 4 (1.28 g, 9.03 mmol) and nitrobenzene , Yield 39%).

GC-Mass (이론치: 726.28 g/mol, 측정치: 726 g/mol)
GC-Mass (calculated: 726.28 g / mol, measured: 726 g / mol)

[합성예 14] Inv-14의 합성[Synthesis Example 14] Synthesis of Inv-14

Figure 112012102547714-pat00126
Figure 112012102547714-pat00126

IC-5 (3 g, 9.03 mmol), 2-(4-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (3.72 g, 10.83 mmol), Pd(OAc)2 (0.10 g, 5 mol%), NaO(t-bu) (2.17 g, 22.56 mmol), P(t-bu)3 (0.18 g, 0.90 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 3과 동일한 방법으로 목적 화합물 Inv-14 (3.75 g, 수율 65 %)을 획득하였다. (3.72 g, 10.83 mmol), Pd (OAc) 2 (0.10 g, 5 mmol), IC-5 (3 g, 9.03 mmol), 2- (4- chlorophenyl) -4,6- mol%), using NaO (t-bu) (2.17 g, 22.56 mmol), P (t-bu) 3 (0.18 g, 0.90 mmol) and Toluene (100 ml), in the same manner as in synthesis example 3 The target compound Inv-14 (3.75 g, yield 65%) was obtained.

GC-Mass (이론치: 639.24 g/mol, 측정치: 639 g/mol)
GC-Mass (calculated: 639.24 g / mol, measured: 639 g / mol)

[합성예 15] Inv-15의 합성[Synthesis Example 15] Synthesis of Inv-15

Figure 112012102547714-pat00127
Figure 112012102547714-pat00127

IC-6 (3 g, 9.03 mmol), 4-bromo-2,6-diphenylpyridine (4.20 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-15 (1.77 g, 수율 35 %)를 획득하였다.(0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), IC-6 (3 g, 9.03 mmol), 4-bromo-2,6-diphenylpyridine (4.20 g, 13.54 mmol) Na 2 SO 4 using a (1.28 g, 9.03 mmol), nitrobenzene (100 ml), to obtain the desired compound of Inv-15 (1.77 g, yield 35%) in the same manner as in synthesis example 1.

GC-Mass (이론치: 561.22 g/mol, 측정치: 561 g/mol)
GC-Mass (calculated: 561.22 g / mol, measured: 561 g / mol)

[합성예 16] Inv-16의 합성[Synthesis Example 16] Synthesis of Inv-16

Figure 112012102547714-pat00128
Figure 112012102547714-pat00128

IC-6 (3 g, 9.03 mmol), 2-(3-bromo-5-methylphenyl)-4,6-diphenyl-1,3,5-triazine (5.45 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-16 (2.36 g, 수율 40 %)를 획득하였다.(5.45 g, 13.54 mmol), Cu powder (0.06 g, 13.54 mmol), IC-6 (3 g, 9.03 mmol), 2- (3-bromo- 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), Na 2 SO 4 (1.28 g, 9.03 mmol), using the nitrobenzene (100 ml), the objective compound in the same manner as in synthesis example 1 Inv- 16 (2.36 g, yield 40%).

GC-Mass (이론치: 653.26 g/mol, 측정치: 653 g/mol)
GC-Mass (calculated: 653.26 g / mol, measured: 653 g / mol)

[합성예 17] Inv-17의 합성[Synthesis Example 17] Synthesis of Inv-17

Figure 112012102547714-pat00129
Figure 112012102547714-pat00129

IC-7 (3 g, 9.03 mmol), 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine (5.37 g, 10.83 mmol), Pd(OAc)2 (0.10 g, 5 mol%), NaO(t-bu) (2.17 g, 22.56 mmol), P(t-bu)3 (0.18 g, 0.90 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 3과 동일한 방법으로 목적 화합물 Inv-17 (4.79 g, 수율 67 %)을 획득하였다. 3-yl) -6- (3-chlorophenyl) -1,3,5-triazine (5.37 g, 10.83 mmol), Pd (OAc ) 2 (0.10 g, 5 mol%), NaO (t-bu) (2.17 g, 22.56 mmol), P (t-bu) 3 (0.18 g, 0.90 mmol) and Toluene In the same manner as in Synthesis Example 3, the desired compound Inv-17 (4.79 g, yield 67%) was obtained.

GC-Mass (이론치: 791.30 g/mol, 측정치: 791 g/mol)
GC-Mass (calculated: 791.30 g / mol, measured: 791 g / mol)

[합성예 18] Inv-18의 합성[Synthesis Example 18] Synthesis of Inv-18

Figure 112012102547714-pat00130
Figure 112012102547714-pat00130

IC-7 (3 g, 9.03 mmol), 2-(3-chlorophenyl)-4,6-di(pyridin-2-yl)pyrimidine (3.73 g, 10.83 mmol), Pd(OAc)2 (0.10 g, 5 mol%), NaO(t-bu) (2.17 g, 22.56 mmol), P(t-bu)3 (0.18 g, 0.90 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 3과 동일한 방법으로 목적 화합물 Inv-18 (3.41 g, 수율 59 %)을 획득하였다. (3.00 g, 10.83 mmol), Pd (OAc) 2 (0.10 g, 5 mmol), IC-7 (3 g, 9.03 mmol), 2- (3- chlorophenyl) -4,6- mol%), using NaO (t-bu) (2.17 g, 22.56 mmol), P (t-bu) 3 (0.18 g, 0.90 mmol) and Toluene (100 ml), in the same manner as in synthesis example 3 The target compound Inv-18 (3.41 g, yield 59%) was obtained.

GC-Mass (이론치: 640.24 g/mol, 측정치: 640 g/mol)
GC-Mass (calculated: 640.24 g / mol, measured: 640 g / mol)

[합성예 19] Inv-19의 합성[Synthesis Example 19] Synthesis of Inv-19

Figure 112012102547714-pat00131
Figure 112012102547714-pat00131

IC-8 (3 g, 9.03 mmol), 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (6.29 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-19 (2.46 g, 수율 38 %)을 획득하였다.3-yl) -4,6-diphenyl-1,3,5-triazine (6.29 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), Na 2 SO 4 (1.28 g, 9.03 mmol), using the nitrobenzene (100 ml), the objective compound in the same manner as in synthesis example 1 Inv- 19 (2.46 g, yield 38%).

GC-Mass (이론치: 715.27 g/mol, 측정치: 715 g/mol)
GC-Mass (calculated: 715.27 g / mol, measured: 715 g / mol)

[합성예 20] Inv-20의 합성[Synthesis Example 20] Synthesis of Inv-20

Figure 112012102547714-pat00132
Figure 112012102547714-pat00132

IC-8 (3 g, 9.03 mmol), 2-(4-bromophenyl)-1-phenyl-1H-benzo[d]imidazole (4.73 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-20 (2.11 g, 수율 39 %)을 획득하였다.D] imidazole (4.73 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 (4 g, Inv-20 (2.11 g, yield: 97%) was obtained in the same manner as in Synthesis Example 1, using the compound CO 3 (1.25 g, 9.03 mmol), Na 2 SO 4 (1.28 g, 9.03 mmol) and nitrobenzene 39%).

GC-Mass (이론치: 600.23 g/mol, 측정치: 600 g/mol)
GC-Mass (theory: 600.23 g / mol, measurement: 600 g / mol)

[합성예 21] Inv-21의 합성[Synthesis Example 21] Synthesis of Inv-21

Figure 112012102547714-pat00133
Figure 112012102547714-pat00133

IC-9 (3 g, 9.03 mmol), 2-(3-bromophenyl)pyridine (3.17 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-21 (1.84 g, 수율 42 %)을 획득하였다.(3.16 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), Na Inv-21 (1.84 g, yield 42%) was obtained in the same manner as in Synthesis Example 1, using 2- SO 4 (1.28 g, 9.03 mmol) and nitrobenzene (100 ml).

GC-Mass (이론치: 485.19 g/mol, 측정치: 485 g/mol)
GC-Mass (calculated: 485.19 g / mol, measured: 485 g / mol)

[합성예 22] Inv-22의 합성[Synthesis Example 22] Synthesis of Inv-22

Figure 112012102547714-pat00134
Figure 112012102547714-pat00134

IC-9 (3 g, 9.03 mmol), 2-chloro-4,6-diphenylpyrimidine (2.89 g, 10.83 mmol), Pd(OAc)2 (0.10 g, 5 mol%), NaO(t-bu) (2.17 g, 22.56 mmol), P(t-bu)3 (0.18 g, 0.90 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 3과 동일한 방법으로 목적 화합물 Inv-22 (3.66 g, 수율 72 %)를 획득하였다. 2-chloro-4,6-diphenylpyrimidine (2.89 g, 10.83 mmol), Pd (OAc) 2 (0.10 g, 5 mol%), NaO (t-Bu) g, 22.56 mmol), P ( t-bu) 3 (0.18 g, 0.90 mmol) and Toluene (100 ml), the same method the desired compound Inv-22 (3.66 g in the above synthesis example 3 using a yield of 72% ).

GC-Mass (이론치: 562.22 g/mol, 측정치: 562 g/mol)
GC-Mass (calculated: 562.22 g / mol, measured: 562 g / mol)

[합성예 23] Inv-23의 합성[Synthesis Example 23] Synthesis of Inv-23

Figure 112012102547714-pat00135
Figure 112012102547714-pat00135

IC-10 (3 g, 9.03 mmol), 2-bromoquinoline (2.82 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-23 (2.32 g, 수율 56 %)을 획득하였다.2-bromoquinoline (2.82 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), Na 2 SO 4 (1.28 g, 9.03 mmol) and nitrobenzene (100 ml), the target compound Inv-23 (2.32 g, yield 56%) was obtained in the same manner as in Synthesis Example 1. [

GC-Mass (이론치: 459.17 g/mol, 측정치: 459 g/mol)
GC-Mass (459.17 g / mol, measured: 459 g / mol)

[합성예 24] Inv-24의 합성[Synthesis Example 24] Synthesis of Inv-24

Figure 112012102547714-pat00136
Figure 112012102547714-pat00136

IC-10 (3 g, 9.03 mmol), 1-bromo-4-phenylisoquinoline (3.85 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K2CO3 (1.25 g, 9.03 mmol), Na2SO4 (1.28 g, 9.03 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-24 (2.56 g, 수율 53 %)를 획득하였다.(3.85 g, 13.54 mmol), Cu powder (0.06 g, 0.90 mmol), K 2 CO 3 (1.25 g, 9.03 mmol), Na 2 Inv-24 (2.56 g, yield 53%) was obtained in the same manner as in Synthesis Example 1, using SO 4 (1.28 g, 9.03 mmol) and nitrobenzene (100 ml).

GC-Mass (이론치: 535.20 g/mol, 측정치: 535 g/mol)
GC-Mass (calculated: 535.20 g / mol, measured: 535 g / mol)

[합성예 25] Inv-25의 합성[Synthesis Example 25] Synthesis of Inv-25

Figure 112012102547714-pat00137
Figure 112012102547714-pat00137

IC-11 (3 g, 7.84 mmol), 2-(4'-chlorobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine (3.95 g, 9.41 mmol), Pd(OAc)2 (0.09 g, 5 mol%), NaO(t-bu) (1.88 g, 19.61 mmol), P(t-bu)3 (0.16 g, 0.78 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 3과 동일한 방법으로 목적 화합물 Inv-25 (3.90 g, 수율 65 %)를 획득하였다. 4-yl) -4,6-diphenyl-1,3,5-triazine (3.95 g, 9.41 mmol), Pd (OAc) 2 (0.09 g, 5 mol%) , using NaO (t-bu) (1.88 g, 19.61 mmol), P (t-bu) 3 (0.16 g, 0.78 mmol) and Toluene (100 ml), the above synthesis example The target compound Inv-25 (3.90 g, yield 65%) was obtained in the same manner as in 3).

GC-Mass (이론치: 765.29 g/mol, 측정치: 765 g/mol)
GC-Mass (calculated: 765.29 g / mol, measured: 765 g / mol)

[합성예 26] Inv-26의 합성[Synthesis Example 26] Synthesis of Inv-26

Figure 112012102547714-pat00138
Figure 112012102547714-pat00138

질소 기류 하에서 IC-12 (3 g, 6.16 mmol)과 3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid (2.61 g, 7.39 mmol), K2CO3 (2.55 g, 18.47 mmol) 및 THF/H2O(100 ml/50 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(0.36 g, 5 mol%)를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane : EA = 3:1 (v/v))로 정제하여 목적 화합물인 Inv-26 (3.48 g, 79 %)을 얻었다. (3 g, 6.16 mmol), 3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenylboronic acid (2.61 g, 7.39 mmol) and K 2 CO 3 2.55 g, 18.47 mmol) and THF / H 2 O (a mixture of 100 ml / 50 ml), then insert the Pd (PPh 3) 4 (0.36 g, 5 mol%) at 40 ℃ stirred at 80 ℃ for 12 hours Respectively. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer, and the residue was purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain the target compound Inv-26 (3.48 g, 79%).

GC-Mass (이론치: 715.27 g/mol, 측정치: 715 g/mol)
GC-Mass (calculated: 715.27 g / mol, measured: 715 g / mol)

[합성예 27] Inv-27의 합성[Synthesis Example 27] Synthesis of Inv-27

Figure 112012102547714-pat00139
Figure 112012102547714-pat00139

IC-12 (3 g, 6.16 mmol), 4-(diphenylamino)phenylboronic acid (2.14 g, 7.39 mmol), Pd(PPh3)4(0.36 g, 5 mol%), K2CO3 (2.55 g, 18.47 mmol) 및 THF/H2O(100 ml/50 ml)를 사용하여, 상기 합성예 26과 동일한 방법으로 목적 화합물인 Inv-27 (3.33 g, 수율 83 %)를 획득하였다.IC-12 (3 g, 6.16 mmol), 4- (diphenylamino) phenylboronic acid (2.14 g, 7.39 mmol), Pd (PPh 3) 4 (0.36 g, 5 mol%), K 2 CO 3 (2.55 g, 18.47 Inv-27 (3.33 g, yield 83%) was obtained in the same manner as in Synthesis Example 26, using 2-

GC-Mass (이론치: 651.27 g/mol, 측정치: 651 g/mol)
GC-Mass (calculated: 651.27 g / mol, measured: 651 g / mol)

[합성예 28] Inv-28의 합성[Synthesis Example 28] Synthesis of Inv-28

Figure 112012102547714-pat00140
Figure 112012102547714-pat00140

IC-12 (3 g, 6.16 mmol), 9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazol-3-ylboronic acid (3.27 g, 7.39 mmol), Pd(PPh3)4(0.36 g, 5 mol%), K2CO3 (2.55 g, 18.47 mmol) 및 THF/H2O(100 ml/50 ml)를 사용하여, 상기 합성예 26과 동일한 방법으로 목적 화합물인 Inv-28 (3.82 g, 수율 77 %)를 획득하였다.3-ylboronic acid (3.27 g, 7.39 mmol), Pd (3 g, 6.16 mmol), IC- with (PPh 3) 4 (0.36 g , 5 mol%), K 2 CO 3 using a (2.55 g, 18.47 mmol) and THF / H 2 O (100 ml / 50 ml), the same procedure as in synthesis example 26 The target compound Inv-28 (3.82 g, yield 77%) was obtained.

GC-Mass (이론치: 804.30 g/mol, 측정치: 804 g/mol)
GC-Mass (theory: 804.30 g / mol, measurement: 804 g / mol)

[합성예 29] Inv-29의 합성[Synthesis Example 29] Synthesis of Inv-29

Figure 112012102547714-pat00141
Figure 112012102547714-pat00141

IC-13 (3 g, 5.32 mmol), iodobenzene (1.63 g, 7.98 mmol), Cu powder (0.03 g, 0.53 mmol), K2CO3 (0.74 g, 5.32 mmol), Na2SO4 (0.76 g, 5.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-29 (1.87 g, 수율 55 %)를 획득하였다.K 2 CO 3 (0.74 g, 5.32 mmol), Na 2 SO 4 (0.76 g, 0.53 mmol), IC powder (3 g, 5.32 mmol), iodobenzene (1.63 g, 5.32 mmol) and nitrobenzene (100 ml), Inv-29 (1.87 g, yield 55%) was obtained in the same manner as in Synthesis Example 1. [

GC-Mass (이론치: 639.24 g/mol, 측정치: 639 g/mol)
GC-Mass (calculated: 639.24 g / mol, measured: 639 g / mol)

[합성예 30] Inv-30의 합성[Synthesis Example 30] Synthesis of Inv-30

Figure 112012102547714-pat00142
Figure 112012102547714-pat00142

IC-13 (3 g, 5.32 mmol), 1-bromo-3,5-diphenyl benzene (2.47 g, 7.98 mmol), Cu powder (0.03 g, 0.53 mmol), K2CO3 (0.74 g, 5.32 mmol), Na2SO4 (0.76 g, 5.32 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-30 (1.81 g, 수율 43 %)을 획득하였다.Cu powder (0.03 g, 0.53 mmol), K 2 CO 3 (0.74 g, 5.32 mmol), IC-13 (3 g, 5.32 mmol), 1-bromo-3,5- , Na 2 using SO 4 (0.76 g, 5.32 mmol ), nitrobenzene (100 ml), was obtained in Inv-30 (1.81 g, yield 43%) of the target compound in the same manner as in synthesis example 1.

GC-Mass (이론치: 791.30 g/mol, 측정치: 791 g/mol)
GC-Mass (calculated: 791.30 g / mol, measured: 791 g / mol)

[합성예 31] Inv-31의 합성[Synthesis Example 31] Synthesis of Inv-31

Figure 112012102547714-pat00143
Figure 112012102547714-pat00143

IC-14 (3 g, 6.18 mmol), iodobenzene (1.89 g, 9.27 mmol), Cu powder (0.06 g, 0.62 mmol), K2CO3 (1.25 g, 6.18 mmol), Na2SO4 (1.28 g, 6.18 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-31 (2.08 g, 수율 60 %)를 획득하였다.K 2 CO 3 (1.25 g, 6.18 mmol), Na 2 SO 4 (1.28 g, 0.62 mmol), IC powder 14 (3 g, 6.18 mmol), iodobenzene (1.89 g, 6.18 mmol) and nitrobenzene (100 ml), Inv-31 (2.08 g, yield 60%) was obtained in the same manner as in Synthesis Example 1. [

GC-Mass (이론치: 561.22 g/mol, 측정치: 561 g/mol)
GC-Mass (calculated: 561.22 g / mol, measured: 561 g / mol)

[합성예 32] Inv-32의 합성[Synthesis Example 32] Synthesis of Inv-32

Figure 112012102547714-pat00144
Figure 112012102547714-pat00144

IC-14 (3 g, 6.18 mmol), 1-bromo-3,5-diphenyl benzene (2.87 g, 9.27 mmol), Cu powder (0.06 g, 0.62 mmol), K2CO3 (1.25 g, 6.18 mmol), Na2SO4 (1.28 g, 6.18 mmol), nitrobenzene (100 ml)을 사용하여, 상기 합성예 1과 동일한 방법으로 목적 화합물인 Inv-32 (1.90 g, 수율 43 %)를 획득하였다.Cu powder (0.06 g, 0.62 mmol), K 2 CO 3 (1.25 g, 6.18 mmol), IC-14 (3 g, 6.18 mmol), 1-bromo-3,5- , Na 2 SO 4 using a (1.28 g, 6.18 mmol), nitrobenzene (100 ml), was obtained in Inv-32 (1.90 g, yield 43%) of the target compound in the same manner as in synthesis example 1.

GC-Mass (이론치: 713.28 g/mol, 측정치: 713 g/mol)
GC-Mass (calculated: 713.28 g / mol, measured: 713 g / mol)

[합성예 33] Inv-33의 합성[Synthesis Example 33] Synthesis of Inv-33

Figure 112012102547714-pat00145
Figure 112012102547714-pat00145

IC-15 (3 g, 8.66 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (3.57 g, 10.39 mmol), Pd(OAc)2 (0.10 g, 5 mol%), NaO(t-bu) (2.08 g, 21.65 mmol), P(t-bu)3 (0.18 g, 0.87 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 3과 동일한 방법으로 목적 화합물 Inv-33 (3.62 g, 수율 64 %)을 획득하였다. (3.57 g, 10.39 mmol), Pd (OAc) 2 (0.10 g, 5 mmol), IC-15 (3 g, 8.66 mmol), 2- (3- chlorophenyl) mol%), using NaO (t-bu) (2.08 g, 21.65 mmol), P (t-bu) 3 (0.18 g, 0.87 mmol) and Toluene (100 ml), in the same manner as in synthesis example 3 The target compound Inv-33 (3.62 g, yield 64%) was obtained.

GC-Mass (이론치: 653.26 g/mol, 측정치: 653 g/mol)
GC-Mass (calculated: 653.26 g / mol, measured: 653 g / mol)

[합성예 34] Inv-34의 합성[Synthesis Example 34] Synthesis of Inv-34

Figure 112012102547714-pat00146
Figure 112012102547714-pat00146

IC-15 (3 g, 8.66 mmol), 2-(3'-chlorobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine (4.36 g, 10.39 mmol), Pd(OAc)2 (0.10 g, 5 mol%), NaO(t-bu) (2.08 g, 21.65 mmol), P(t-bu)3 (0.18 g, 0.87 mmol) 및 Toluene (100 ml)을 사용하여, 상기 합성예 3과 동일한 방법으로 목적 화합물 Inv-34 (3.73 g, 수율 59 %)를 획득하였다. 3-yl) -4,6-diphenyl-1,3,5-triazine (4.36 g, 10.39 mmol), Pd (OAc) 2 (0.10 g, 5 mol%), NaO (t-bu) (2.08 g, 21.65 mmol), P (t-bu) 3 (0.18 g, 0.87 mmol) and Toluene The objective compound Inv-34 (3.73 g, yield 59%) was obtained in the same manner as in 3).

GC-Mass (이론치: 729.29 g/mol, 측정치: 729 g/mol)
GC-Mass (calculated: 729.29 g / mol, measured: 729 g / mol)

[실시예 1 ~ 34] 유기 EL 소자의 제작[Examples 1 to 34] Fabrication of organic EL device

합성예 1 내지 합성예 34에서 합성된 각 화합물 Inv-1 ~ Inv-34을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 하기 과정에 따라 녹색 유기 EL 소자를 제작하였다.Each of the compounds Inv-1 to Inv-34 synthesized in Synthesis Examples 1 to 34 was subjected to high purity sublimation purification by a known method, and then a green organic EL device was manufactured according to the following procedure.

먼저, ITO (Indium tin oxide)가 1500 ㅕ 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium Tin Oxide) with a thickness of 1500 ㅕ was washed with distilled water ultrasonic waves. After the distilled water was washed, the substrate was ultrasonically washed with a solvent such as isopropyl alcohol, acetone, or methanol, dried and transferred to a UV OZONE cleaner (Power Sonic 405, Hoshin Tech), the substrate was cleaned using UV for 5 minutes, The substrate was transferred.

이렇게 준비된 ITO 투명 전극 위에 m-MTDATA (60 nm)/TCTA (80 nm)/Inv-1 ~ Inv-34의 각각의 화합물 + 10 % Ir(ppy)3 (300nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 EL 소자를 제작하였다. Each compound of m-MTDATA (60 nm) / TCTA (80 nm) / Inv-1 to Inv-34 + 10% Ir (ppy) 3 (300 nm) / BCP (10 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) in that order.

m-MTDATA, TCTA, Ir(ppy)3, CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 , CBP and BCP are as follows.

Figure 112012102547714-pat00147
Figure 112012102547714-pat00147

Figure 112012102547714-pat00148
Figure 112012102547714-pat00148

[비교예 1] 유기 EL 소자의 제작[Comparative Example 1] Fabrication of organic EL device

발광층 형성시 발광 호스트 물질로서 화합물 Inv-1 대신 CBP를 사용하는 것을 제외하고는, 상기 실시예 1과 동일한 과정으로 유기 EL 소자를 제작하였다.
An organic EL device was fabricated in the same manner as in Example 1 except that CBP was used instead of the compound Inv-1 as a luminescent host material in forming the light emitting layer.

[평가예][Evaluation example]

실시예 1-34 및 비교예 1에서 제작된 각각의 유기 EL 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.The driving voltage, current efficiency and emission peak at a current density of 10 mA / cm 2 were measured for each of the organic EL devices manufactured in Example 1-34 and Comparative Example 1, and the results are shown in Table 1 below.

샘플Sample 호스트Host 구동 전압
(V)
Driving voltage
(V)
EL 피크
(nm)
EL peak
(nm)
전류효율
(cd/A)
Current efficiency
(cd / A)
실시예 1Example 1 Inv-1Inv-1 6.656.65 516516 41.841.8 실시예 2Example 2 Inv-2Inv-2 6.636.63 517517 40.740.7 실시예 3Example 3 Inv-3Inv-3 6.626.62 516516 43.243.2 실시예 4Example 4 Inv-4Inv-4 6.656.65 516516 43.543.5 실시예 5Example 5 Inv-5Inv-5 6.706.70 516516 41.741.7 실시예 6Example 6 Inv-6Inv-6 6.676.67 516516 41.141.1 실시예 7Example 7 Inv-7Inv-7 6.626.62 517517 42.642.6 실시예 8Example 8 Inv-8Inv-8 6.836.83 517517 39.639.6 실시예 9Example 9 Inv-9Inv-9 6.756.75 518518 39.839.8 실시예 10Example 10 Inv-10Inv-10 6.726.72 518518 39.339.3 실시예 11Example 11 Inv-11Inv-11 6.746.74 515515 40.240.2 실시예 12Example 12 Inv-12Inv-12 6.626.62 516516 41.041.0 실시예 13Example 13 Inv-13Inv-13 6.656.65 517517 41.341.3 실시예 14Example 14 Inv-14Inv-14 6.816.81 518518 39.739.7 실시예 15Example 15 Inv-15Inv-15 6.726.72 516516 40.240.2 실시예 16Example 16 Inv-16Inv-16 6.636.63 517517 41.341.3 실시예 17Example 17 Inv-17Inv-17 6.846.84 517517 39.739.7 실시예 18Example 18 Inv-18Inv-18 6.636.63 516516 40.540.5 실시예 19Example 19 Inv-19Inv-19 6.686.68 518518 41.341.3 실시예 20Example 20 Inv-20Inv-20 6.646.64 517517 41.541.5 실시예 21Example 21 Inv-21Inv-21 6.786.78 516516 41.241.2 실시예 22Example 22 Inv-22Inv-22 6.656.65 517517 40.540.5 실시예 23Example 23 Inv-23Inv-23 6.806.80 516516 39.339.3 실시예 24Example 24 Inv-24Inv-24 6.816.81 515515 39.639.6 실시예 25Example 25 Inv-25Inv-25 6.856.85 517517 38.838.8 실시예 26Example 26 Inv-26Inv-26 6.756.75 516516 39.639.6 실시예 27Example 27 Inv-27Inv-27 6.656.65 517517 42.542.5 실시예 28Example 28 Inv-28Inv-28 6.676.67 518518 41.041.0 실시예 29Example 29 Inv-29Inv-29 6.686.68 517517 40.540.5 실시예 30Example 30 Inv-30Inv-30 6.716.71 517517 41.441.4 실시예 31Example 31 Inv-31Inv-31 6.736.73 518518 40.340.3 실시예 32Example 32 Inv-32Inv-32 6.696.69 518518 40.240.2 실시예 33Example 33 Inv-33Inv-33 6.786.78 517517 41.141.1 실시예 34Example 34 Inv-34Inv-34 6.836.83 516516 39.539.5 비교예 1Comparative Example 1 CBPCBP 6.936.93 516516 38.238.2

상기 표 1에 나타낸 바와 같이, 본 발명에 따른 화합물(Inv-1 ~ Inv-34)을 발광층으로 사용하는 실시예 1-34의 녹색 유기 EL 소자는, 종래 CBP를 사용하는 비교예 1의 녹색 유기 EL 소자와 비교해 볼 때 효율 및 구동전압 면에서 우수한 성능을 나타내는 것을 알 수 있다.As shown in Table 1, the green organic EL device of Example 1-34, in which the compound (Inv-1 to Inv-34) according to the present invention was used as a light emitting layer, It can be seen that the EL device exhibits excellent performance in terms of efficiency and driving voltage.

이상을 통해 본 발명의 바람직한 실시예에 대하여 설명하였지만, 본 발명은 이에 한정되는 것이 아니고 특허청구범위와 발명의 상세한 설명의 범위 안에서 여러 가지로 변형하여 실시하는 것이 가능하고 이 또한 발명의 범주에 속하는 것은 당연하다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, It is natural.

Claims (9)

하기 화학식 1로 표시되는 화합물:
[화학식 1]
Figure 112015039058634-pat00149

상기 화학식 1에서,
R5와 R6, R6와 R7, 및 R7과 R8 중 적어도 하나는 하기 화학식 2와 결합하여 축합 고리를 형성하고;
[화학식 2]
Figure 112015039058634-pat00150

상기 화학식 2에서,
R9와 R10, R10과 R11, 및 R11과 R12 중 적어도 하나는 상기 화학식 1과 결합하여 축합 고리를 형성하고;
축합고리를 비형성하는 R1 내지 R12 는 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C6~C40의 아릴기, 및 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군에서 선택되고, 이때 R1과 R2, R2와 R3, 또는 R3와 R4는 결합하여 축합 고리를 형성할 수 있으며,
X1 및 X2는 각각 독립적으로 N(Ar1)이며,
Y1 및 Y2는 서로 동일하거나 또는 상이하며, 각각 독립적으로 N 및 C(R13)로부터 선택되고,
R13은 수소, 중수소, 치환 또는 비치환된 C1~C40의 알킬기, 치환 또는 비치환된 C6~C40의 아릴기, 및 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군에서 선택되고,
Ar1는 서로 동일하거나 또는 상이하며, 각각 독립적으로 치환 또는 비치환된 C6~C40의 아릴기, 및 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군에서 선택되고,
상기 C1~C40의 알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기가 치환될 경우는, 각각 독립적으로 C1~C40의 알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, 및 C6~C40의 아릴아민기로 이루어진 군으로부터 선택되는 하나 이상의 치환기로 치환됨을 의미함.
A compound represented by the following formula (1):
[Chemical Formula 1]
Figure 112015039058634-pat00149

In Formula 1,
At least one of R 5 and R 6 , R 6 and R 7 , and R 7 and R 8 is bonded to the following formula 2 to form a condensed ring;
(2)
Figure 112015039058634-pat00150

In Formula 2,
At least one of R 9 and R 10, R 10 and R 11 , and at least one of R 11 and R 12 is bonded to Formula 1 to form a condensed ring;
R 1 to R 12 which do not form a condensed ring are the same as or different from each other and each independently represents hydrogen, deuterium, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 6 to C 40 aryl And a substituted or unsubstituted heteroaryl group having 5 to 40 nucleus atoms, wherein R 1 and R 2 , R 2 and R 3 , or R 3 and R 4 combine to form a condensed ring In addition,
X 1 and X 2 are each independently N (Ar 1 )
Y 1 and Y 2 are the same or different and are each independently selected from N and C (R 13 )
R 13 is a hydrogen atom, a heavy hydrogen atom, a substituted or unsubstituted C 1 to C 40 alkyl group, a substituted or unsubstituted C 6 to C 40 aryl group, and a substituted or unsubstituted heteroaryl group having 5 to 40 nuclear atoms &Lt; / RTI &gt;
Ar 1 is the same or different and is selected from the group consisting of a substituted or unsubstituted C 6 to C 40 aryl group and a substituted or unsubstituted heteroaryl group having 5 to 40 nucleus atoms,
When the C 1 to C 40 alkyl group, the C 6 to C 40 aryl group, and the heteroaryl group having 5 to 40 nuclear atoms are substituted, each independently represents a C 1 to C 40 alkyl group, a C 6 to C 40 An aryl group, a heteroaryl group having 5 to 40 nuclear atoms, and an arylamine group having 6 to 40 carbon atoms.
제1항에 있어서, 상기 화학식 1로 표시되는 화합물은 하기 화학식 3 내지 화학식 20 중 어느 하나로 표시되는 것을 특징으로 하는 화합물:
[화학식 3]
Figure 112012102547714-pat00151

[화학식 4]
Figure 112012102547714-pat00152

[화학식 5]
Figure 112012102547714-pat00153

[화학식 6]
Figure 112012102547714-pat00154

[화학식 7]
Figure 112012102547714-pat00155

[화학식 8]
Figure 112012102547714-pat00156

[화학식 9]
Figure 112012102547714-pat00157

[화학식 10]
Figure 112012102547714-pat00158

[화학식 11]
Figure 112012102547714-pat00159

[화학식 12]
Figure 112012102547714-pat00160

[화학식 13]
Figure 112012102547714-pat00161

[화학식 14]
Figure 112012102547714-pat00162

[화학식 15]
Figure 112012102547714-pat00163

[화학식 16]
Figure 112012102547714-pat00164

[화학식 17]
Figure 112012102547714-pat00165

[화학식 18]
Figure 112012102547714-pat00166

[화학식 19]
Figure 112012102547714-pat00167

[화학식 20]
Figure 112012102547714-pat00168

상기 화학식 3 내지 화학식 20 에서,
R1 내지 R12, X1 및 X2, Y1 및 Y2 은 각각 제1항에서 정의된 바와 같다.
2. The compound according to claim 1, wherein the compound represented by the formula (1) is represented by any one of the following formulas (3) to (20)
(3)
Figure 112012102547714-pat00151

[Chemical Formula 4]
Figure 112012102547714-pat00152

[Chemical Formula 5]
Figure 112012102547714-pat00153

[Chemical Formula 6]
Figure 112012102547714-pat00154

(7)
Figure 112012102547714-pat00155

[Chemical Formula 8]
Figure 112012102547714-pat00156

[Chemical Formula 9]
Figure 112012102547714-pat00157

[Chemical formula 10]
Figure 112012102547714-pat00158

(11)
Figure 112012102547714-pat00159

[Chemical Formula 12]
Figure 112012102547714-pat00160

[Chemical Formula 13]
Figure 112012102547714-pat00161

[Chemical Formula 14]
Figure 112012102547714-pat00162

[Chemical Formula 15]
Figure 112012102547714-pat00163

[Chemical Formula 16]
Figure 112012102547714-pat00164

[Chemical Formula 17]
Figure 112012102547714-pat00165

[Chemical Formula 18]
Figure 112012102547714-pat00166

[Chemical Formula 19]
Figure 112012102547714-pat00167

[Chemical Formula 20]
Figure 112012102547714-pat00168

In the above Chemical Formulas 3 to 20,
R 1 to R 12, X 1 and X 2 , Y 1 and Y 2 are as defined in claim 1, respectively.
제1항에 있어서, 상기 Y1 및 Y2는 C(R13)이며,
R13은 각각 독립적으로 수소, 중수소, C1~C40의 알킬기, C6~C40의 아릴기, 및 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군에서 선택되는 것을 특징으로 하는 화합물.
The compound according to claim 1, wherein Y 1 and Y 2 are C (R 13 )
R 13 is a compound characterized in that each independently hydrogen, deuterium, C 1 ~ C 40 alkyl group, C 6 ~ C 40 aryl group, and the number of nuclear atoms selected from the group consisting of 5 to 40 heteroaryl group of.
제1항에 있어서, 상기 화학식 1로 표시되는 화합물은 하기 화학식 21 내지 화학식 38 중 어느 하나로 표시되는 것을 특징으로 하는 화합물:
[화학식 21]
Figure 112012102547714-pat00169

[화학식 22]
Figure 112012102547714-pat00170

[화학식 23]
Figure 112012102547714-pat00171

[화학식 24]
Figure 112012102547714-pat00172

[화학식 25]
Figure 112012102547714-pat00173

[화학식 26]
Figure 112012102547714-pat00174

[화학식 27]
Figure 112012102547714-pat00175

[화학식 28]
Figure 112012102547714-pat00176

[화학식 29]
Figure 112012102547714-pat00177

[화학식 30]
Figure 112012102547714-pat00178

[화학식 31]
Figure 112012102547714-pat00179

[화학식 32]
Figure 112012102547714-pat00180

[화학식 33]
Figure 112012102547714-pat00181

[화학식 34]
Figure 112012102547714-pat00182

[화학식 35]
Figure 112012102547714-pat00183

[화학식 36]
Figure 112012102547714-pat00184

[화학식 37]
Figure 112012102547714-pat00185

[화학식 38]
Figure 112012102547714-pat00186

상기 화학식 21 내지 화학식 38 에서,
R1 내지 R13 및 Ar1 은 각각 제1항에서 정의한 바와 동일하다.
The compound according to claim 1, wherein the compound represented by the formula (1) is represented by any one of the following formulas (21) to (38)
[Chemical Formula 21]
Figure 112012102547714-pat00169

[Chemical Formula 22]
Figure 112012102547714-pat00170

(23)
Figure 112012102547714-pat00171

&Lt; EMI ID =
Figure 112012102547714-pat00172

(25)
Figure 112012102547714-pat00173

(26)
Figure 112012102547714-pat00174

(27)
Figure 112012102547714-pat00175

(28)
Figure 112012102547714-pat00176

[Chemical Formula 29]
Figure 112012102547714-pat00177

(30)
Figure 112012102547714-pat00178

(31)
Figure 112012102547714-pat00179

(32)
Figure 112012102547714-pat00180

(33)
Figure 112012102547714-pat00181

(34)
Figure 112012102547714-pat00182

(35)
Figure 112012102547714-pat00183

(36)
Figure 112012102547714-pat00184

(37)
Figure 112012102547714-pat00185

(38)
Figure 112012102547714-pat00186

In the above Formulas 21 to 38,
R 1 to R 13 and Ar 1 are the same as defined in claim 1 , respectively.
삭제delete 삭제delete 제1항에 있어서, 상기 Ar1는 각각 독립적으로 하기 치환체 군에서 선택되는 것을 특징으로 하는 화합물.
Figure 112015039058634-pat00187
2. A compound according to claim 1, wherein Ar &lt; 1 &gt; is each independently selected from the following Substituent group.
Figure 112015039058634-pat00187
양극, 음극, 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며,
상기 1층 이상의 유기물층 중 적어도 하나는 제 1항 내지 제4항, 및 제 7항 중 어느 한 항에 기재된 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자.
A cathode, and at least one organic layer interposed between the anode and the cathode,
Wherein at least one of the one or more organic layers includes a compound according to any one of claims 1 to 4 or 7.
제 8항에 있어서, 상기 화합물을 포함하는 적어도 하나의 유기물층은 발광층인 것을 특징으로 하는 유기 전계 발광 소자.The organic electroluminescent device according to claim 8, wherein at least one organic compound layer containing the compound is a light emitting layer.
KR1020120143013A 2012-12-10 2012-12-10 Organic compounds and organic electro luminescence device comprising the same KR101571591B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020120143013A KR101571591B1 (en) 2012-12-10 2012-12-10 Organic compounds and organic electro luminescence device comprising the same
PCT/KR2013/010557 WO2014092354A1 (en) 2012-12-10 2013-11-20 Organic compound and organic electroluminescent element comprising same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120143013A KR101571591B1 (en) 2012-12-10 2012-12-10 Organic compounds and organic electro luminescence device comprising the same

Publications (2)

Publication Number Publication Date
KR20140074729A KR20140074729A (en) 2014-06-18
KR101571591B1 true KR101571591B1 (en) 2015-11-24

Family

ID=50934593

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120143013A KR101571591B1 (en) 2012-12-10 2012-12-10 Organic compounds and organic electro luminescence device comprising the same

Country Status (2)

Country Link
KR (1) KR101571591B1 (en)
WO (1) WO2014092354A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102606391B1 (en) * 2015-02-12 2023-11-27 롬엔드하스전자재료코리아유한회사 Organic Electroluminescent Compounds and Organic Electroluminescent Device Comprising the Same
KR102613166B1 (en) 2015-03-13 2023-12-14 롬엔드하스전자재료코리아유한회사 A plurality of host materials and organic electroluminescent device comprising the same
WO2016148390A1 (en) * 2015-03-13 2016-09-22 Rohm And Haas Electronic Materials Korea Ltd. A plurality of host materials and organic electroluminescent device comprising the same
KR102544984B1 (en) * 2016-03-18 2023-06-20 삼성디스플레이 주식회사 Compound and Organic light emitting device comprising same
CN106749315B (en) * 2016-12-22 2018-11-20 山东大学 8- hexyl-thieno [3 ', 2 ':3,4] benzo [1,2-c] carbazole compound and its synthetic method
CN113045585A (en) * 2021-03-16 2021-06-29 吉林奥来德光电材料股份有限公司 Organic fused ring compound and preparation method and application thereof
CN117683046A (en) * 2022-08-22 2024-03-12 陕西莱特光电材料股份有限公司 Organic compound, organic electroluminescent device and electronic apparatus
CN117683047A (en) * 2022-08-22 2024-03-12 陕西莱特光电材料股份有限公司 Organic compound, organic electroluminescent device and electronic apparatus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010126234A1 (en) 2009-04-29 2010-11-04 Dow Advanced Display Materials,Ltd. Novel organic electroluminescent compounds and organic electroluminescent device using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2145936A3 (en) * 2008-07-14 2010-03-17 Gracel Display Inc. Fluorene and pyrene derivatives and organic electroluminescent device using the same
KR20100106014A (en) * 2009-03-23 2010-10-01 다우어드밴스드디스플레이머티리얼 유한회사 Novel organic electroluminescent compounds and organic electroluminescent device using the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010126234A1 (en) 2009-04-29 2010-11-04 Dow Advanced Display Materials,Ltd. Novel organic electroluminescent compounds and organic electroluminescent device using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Org. Chem. 2012, 77, pp.585~597

Also Published As

Publication number Publication date
WO2014092354A1 (en) 2014-06-19
KR20140074729A (en) 2014-06-18

Similar Documents

Publication Publication Date Title
KR20180022574A (en) Organic compounds and organic electro luminescence device comprising the same
KR101571591B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101601355B1 (en) Novel organic compounds and organic electro luminescence device comprising the same
KR101601356B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20140111898A (en) Organic compounds and organic electro luminescence device comprising the same
KR101599597B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101506793B1 (en) Organic electro luminescence device
KR20180022189A (en) Organic compounds and organic electro luminescence device comprising the same
KR20150030794A (en) Organic compounds and organic electro luminescence device comprising the same
KR101641409B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101571598B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101571600B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150008678A (en) Organic compounds and organic electro luminescence device comprising the same
KR20140145451A (en) Organic compounds and organic electro luminescence device comprising the same
KR101634852B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150103968A (en) Organic compounds and organic electro luminescence device comprising the same
KR101556819B1 (en) Organic compounds and organic electro luminescence device using the same
KR101548040B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101576566B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101622809B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20140064563A (en) Organic compound and organic electroluminescent device comprising the same
KR102507368B1 (en) Organic compound and organic electroluminescent device using the same
KR20160079548A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR20150086107A (en) Organic compounds and organic electro luminescence device comprising the same
KR101612154B1 (en) Organic compounds and organic electro luminescence device comprising the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20191101

Year of fee payment: 5